Gene	Variant_Classification	Alteration	Tumor_allele	Reference_allele	dbSNP_RS	bin	Score_bin	Chromosome	Start_position	End_position	Coverage	Allelic_fraction	Number_of_Probes	Segment_Mean	In_Segment	Pathways	COSMIC_overlapping_mutations	COSMIC_total_alterations_in_gene	UniProt_Region	Rationale	Tumor_Sample_Barcode	Clinical_trials	mutation.assessor
ERBB4	Missense_Mutation	p.R1174Q	C	C		1	Investigate Actionability	2	212248746	212248746	84	0.107142857142857	NA	NA	NA		p.R1174Q(1)	179		Mutations may predict sensitivity to Lapatinib and other anti-EGF family inhibitors	MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ERBB4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,212248746,C,C&fts=all">p.R1174Q</a>
TP53	Missense_Mutation	p.P278R	G	G		1	Investigate Actionability	17	7577105	7577105	32	0.71875	NA	NA	NA		p.P278L(61)|p.P278R(30)|p.P278H(13)|p.0?(8)|p.P278F(3)|p.?(2)|p.P278fs*67(2)|p.A276_R283delACPGRDRR(1)|p.C275fs*20(1)|p.A276fs*64(1)|p.L265_K305del41(1)|p.F270_D281del12(1)|p.V274_P278del(1)|p.S269fs*21(1)|p.V272_K292del21(1)|p.C275_R283delCACPGRDRR(1)	24185	Interaction with AXIN1. {ECO:0000250}.|Interaction with DNA.|Interaction with E4F1.|Interaction with HIPK1. {ECO:0000250}.|Required for interaction with ZNF385A.	Biallelic inactivation or mutation may be prognostic in some tumor types.  They may also predict sensitivity to some cell cycle inhibitors and p53 specific gene therapies or immunotherapies. May signal the presence of a germline mutation.	MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TP53&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7577105,G,G&fts=all">p.P278R</a>
FLT3	Missense_Mutation	p.H809D	G	G		1.75	High Priority	13	28592720	28592720	77	0.337662337662338	NA	NA	NA			12390	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.	Mutations predict sensitivity to FLT3 inhibitors, sunitinib.  Secondary mutations predict resistance.	MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,28592720,G,G&fts=all">p.H809D</a>
CDKN2A	Missense_Mutation	p.P63L	G	G	rs387906410|rs121913386	2	High Priority	9	21971017	21971017	22	0.727272727272727	NA	NA	NA		p.0?(1315)|p.?(44)|p.P114L(27)|p.P114H(3)|p.H83fs*2(2)|p.V115fs*11(1)|p.0(1)|p.A68fs*3(1)|p.A169A(1)	4199		Biallelic inactivation may predict sensitivity to CDK4/6 inhibitors.	MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKN2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,21971017,G,G&fts=all">p.P63L</a>
WT1	Missense_Mutation	p.G126R	C	C		2	High Priority	11	32421580	32421580	45	0.622222222222222	NA	NA	NA			533		May signal the presence of a germline mutation.	MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,32421580,C,C&fts=all">p.G126R</a>
ZBTB16	Missense_Mutation	p.V272F	G	G		3.16666666666667	Cancer Pathway Linked to: CDKN2A; FLT3; TP53	11	113934836	113934836	29	0.137931034482759	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZBTB16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,113934836,G,G&fts=all">p.V272F</a>
ARID2	Missense_Mutation	p.P640S	C	C		4	Cancer Gene Census	12	46243824	46243824	115	0.356521739130435	NA	NA	NA			116			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46243824,C,C&fts=all">p.P640S</a>
ARID2	Missense_Mutation	p.P640L	C	C		4	Cancer Gene Census	12	46243825	46243825	116	0.362068965517241	NA	NA	NA			116			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARID2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,46243825,C,C&fts=all">p.P640L</a>
CSF2RA	Missense_Mutation	p.E379K	G	G		4.16666666666667	Cancer Pathway Linked to: CDKN2A; FLT3; TP53	X	1428304	1428304	53	0.339622641509434	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		45			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSF2RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,1428304,G,G&fts=all">p.E379K</a>
STK36	Missense_Mutation	p.P252S	C	C	rs149860283	4.16666666666667	Cancer Pathway Linked to: CDKN2A; FLT3; TP53	2	219543960	219543960	88	0.159090909090909	NA	NA	NA	 KEGG_PATHWAYS_IN_CANCER  | 		52			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STK36&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219543960,C,C&fts=all">p.P252S</a>
TF	Missense_Mutation	p.T269I	C	C		4.16666666666667	Cancer Pathway Linked to: CDKN2A; FLT3; TP53	3	133475789	133475789	47	0.468085106382979	NA	NA	NA	 BIOCARTA_41BB_PATHWAY  |  KEGG_PROSTATE_CANCER  |  BIOCARTA_P27_PATHWAY  |  KEGG_THYROID_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		49	Transferrin-like 1. {ECO:0000255|PROSITE- ProRule:PRU00741}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,133475789,C,C&fts=all">p.T269I</a>
APAF1	Missense_Mutation	p.G1149E	G	G		4.5	Cancer Pathway Linked to: TP53	12	99119308	99119308	102	0.245098039215686	NA	NA	NA	 KEGG_SMALL_CELL_LUNG_CANCER  | 		42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APAF1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,99119308,G,G&fts=all">p.G1149E</a>
HR	Missense_Mutation	p.N884S	T	T		4.5	Cancer Pathway Linked to: ERBB4	8	21977980	21977980	79	0.518987341772152	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  |  BIOCARTA_IGF1R_PATHWAY  |  BIOCARTA_LONGEVITY_PATHWAY  |  KEGG_THYROID_CANCER  |  BIOCARTA_EGF_PATHWAY  |  BIOCARTA_GLEEVEC_PATHWAY  |  BIOCARTA_HER2_PATHWAY  |  BIOCARTA_MET_PATHWAY  |  KEGG_BLADDER_CANCER  |  KEGG_NON_SMALL_CELL_LUNG_CANCER  |  KEGG_ENDOMETRIAL_CANCER  |  KEGG_RENAL_CELL_CARCINOMA  |  KEGG_PROSTATE_CANCER  |  KEGG_PATHWAYS_IN_CANCER  | 		27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,21977980,T,T&fts=all">p.N884S</a>
ACTN1	Missense_Mutation	p.N366K	A	A		5	Cancer Pathway	14	69356992	69356992	38	0.236842105263158	NA	NA	NA	 BIOCARTA_CELL2CELL_PATHWAY  | 		27	Interaction with DDN.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ACTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,69356992,A,A&fts=all">p.N366K</a>
CUZD1	Missense_Mutation	p.S219F	G	G		5	Cancer Pathway	10	124596508	124596508	44	0.386363636363636	NA	NA	NA	 BIOCARTA_CDMAC_PATHWAY  | 		39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUZD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124596508,G,G&fts=all">p.S219F</a>
ITGA4	Missense_Mutation	p.E908K	G	G		5	Cancer Pathway	2	182396441	182396441	175	0.24	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		58			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,182396441,G,G&fts=all">p.E908K</a>
KLRD1	Missense_Mutation	p.L88F	C	C		5	Cancer Pathway	12	10464161	10464161	130	0.246153846153846	NA	NA	NA	 REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL  | 		10	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10464161,C,C&fts=all">p.L88F</a>
PEX1	Missense_Mutation	p.G1214E	C	C		5	Cancer Pathway	7	92116811	92116811	172	0.215116279069767	NA	NA	NA	 BIOCARTA_SET_PATHWAY  | 		41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PEX1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,92116811,C,C&fts=all">p.G1214E</a>
PFKL	Missense_Mutation	p.A456V	C	C		6	Cancer Pathway	21	45742044	45742044	35	0.314285714285714	NA	NA	NA	 BIOCARTA_GLYCOLYSIS_PATHWAY  | 		23	C-terminal regulatory PFK domain 2.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PFKL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,45742044,C,C&fts=all">p.A456V</a>
SLC7A9	Missense_Mutation	p.P261S	G	G		6	Cancer Pathway	19	33350839	33350839	25	0.36	NA	NA	NA	 REACTOME_BASIGIN_INTERACTIONS  | 		32			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,33350839,G,G&fts=all">p.P261S</a>
BTK	Missense_Mutation	p.D504N	C	C		6.75	Cancer Module	X	100611096	100611096	53	0.735849056603774	NA	NA	NA			50	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BTK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,100611096,C,C&fts=all">p.D504N</a>
EPHB1	Missense_Mutation	p.R682C	C	C		6.75	Cancer Module	3	134911579	134911579	28	0.571428571428571	NA	NA	NA			130	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPHB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,134911579,C,C&fts=all">p.R682C</a>
ABRA	Missense_Mutation	p.A78V	G	G		7	Cancer Module	8	107782186	107782186	97	0.371134020618557	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABRA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,107782186,G,G&fts=all">p.A78V</a>
ADAM2	Missense_Mutation	p.G96E	C	C		7	Cancer Module	8	39679162	39679162	64	0.515625	NA	NA	NA			53			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39679162,C,C&fts=all">p.G96E</a>
ADORA3	Missense_Mutation	p.S170F	G	G		7	Cancer Module	1	112043020	112043020	144	0.513888888888889	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADORA3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,112043020,G,G&fts=all">p.S170F</a>
AFP	Missense_Mutation	p.G345E	G	G		7	Cancer Module	4	74313369	74313369	90	0.188888888888889	NA	NA	NA			22	Albumin 2. {ECO:0000255|PROSITE- ProRule:PRU00769}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AFP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,74313369,G,G&fts=all">p.G345E</a>
AHR	Missense_Mutation	p.P480L	C	C		7	Cancer Module	7	17378888	17378888	129	0.37984496124031	NA	NA	NA			33			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AHR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,17378888,C,C&fts=all">p.P480L</a>
ALOX15B	Missense_Mutation	p.S366F	C	C		7	Cancer Module	17	7948901	7948901	21	0.523809523809524	NA	NA	NA		p.S366F(1)	24	Lipoxygenase. {ECO:0000255|PROSITE- ProRule:PRU00726}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALOX15B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,7948901,C,C&fts=all">p.S366F</a>
AQR	Missense_Mutation	p.P265L	G	G		7	Cancer Module	15	35224625	35224625	59	0.152542372881356	NA	NA	NA			57			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,35224625,G,G&fts=all">p.P265L</a>
ARHGAP15	Copy Number	Amplified	NA	NA	NA	7	Cancer Module	2	144194613	144765104	NA	NA	13	3.75550719359018	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP15&recr=Open">Click here</a>	
ATP10B	Missense_Mutation	p.G1321E	C	C		7	Cancer Module	5	159992884	159992884	118	0.372881355932203	NA	NA	NA			75			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP10B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,159992884,C,C&fts=all">p.G1321E</a>
BGN	Missense_Mutation	p.P3L	C	C		7	Cancer Module	X	152770097	152770097	16	0.8125	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BGN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,152770097,C,C&fts=all">p.P3L</a>
BLNK	Nonsense_Mutation	p.K413*	T	T		7	Cancer Module	10	97956678	97956678	68	0.397058823529412	NA	NA	NA			14	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLNK&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,97956678,T,T&fts=all">p.K413*</a>
BSN	Missense_Mutation	p.T2845I	C	C		7	Cancer Module	3	49695523	49695523	40	0.2	NA	NA	NA			106			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BSN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49695523,C,C&fts=all">p.T2845I</a>
CACNA1A	Missense_Mutation	p.D1102N	C	C	rs372823282	7	Cancer Module	19	13397566	13397566	9	0.444444444444444	NA	NA	NA			42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CACNA1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,13397566,C,C&fts=all">p.D1102N</a>
CATSPERB	Missense_Mutation	p.R269C	G	G	rs139686935	7	Cancer Module	14	92159496	92159496	176	0.607954545454545	NA	NA	NA		p.R269C(1)	54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92159496,G,G&fts=all">p.R269C</a>
CATSPERB	Missense_Mutation	p.G21E	C	C		7	Cancer Module	14	92195762	92195762	80	0.625	NA	NA	NA			54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CATSPERB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92195762,C,C&fts=all">p.G21E</a>
CCDC68	Missense_Mutation	p.S237F	G	G		7	Cancer Module	18	52586581	52586581	119	0.53781512605042	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC68&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,52586581,G,G&fts=all">p.S237F</a>
CEACAM5	Missense_Mutation	p.N658S	A	A		7	Cancer Module	19	42225046	42225046	77	0.337662337662338	NA	NA	NA		p.N659S(1)	34	Ig-like 7.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEACAM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,42225046,A,A&fts=all">p.N658S</a>
CHD7	Missense_Mutation	p.S103L	C	C		7	Cancer Module	8	61654299	61654299	39	0.641025641025641	NA	NA	NA		p.S103L(2)	123			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHD7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,61654299,C,C&fts=all">p.S103L</a>
CHRM3	Missense_Mutation	p.M300I	G	G		7	Cancer Module	1	240071651	240071651	37	0.675675675675676	NA	NA	NA			51			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRM3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240071651,G,G&fts=all">p.M300I</a>
CHRNA2	Missense_Mutation	p.D246N	C	C		7	Cancer Module	8	27321224	27321224	45	0.244444444444444	NA	NA	NA			23			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHRNA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,27321224,C,C&fts=all">p.D246N</a>
CNTNAP2	Missense_Mutation	p.R122K	G	G		7	Cancer Module	7	146536959	146536959	33	0.393939393939394	NA	NA	NA			188	F5/8 type C. {ECO:0000255|PROSITE- ProRule:PRU00081}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,146536959,G,G&fts=all">p.R122K</a>
CNTNAP2	Splice_Site	p.G362E	G	G		7	Cancer Module	7	146829338	146829338	134	0.447761194029851	NA	NA	NA		p.G362E(1)	188	Laminin G-like 1. {ECO:0000255|PROSITE- ProRule:PRU00122}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNTNAP2&recr=Open">Click here</a>	
COL17A1	Missense_Mutation	p.M527I	C	C	rs143399084	7	Cancer Module	10	105815646	105815646	45	0.244444444444444	NA	NA	NA			62	Nonhelical region (NC16).		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL17A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,105815646,C,C&fts=all">p.M527I</a>
COL1A2	Missense_Mutation	p.R675C	C	C		7	Cancer Module	7	94047862	94047862	151	0.211920529801325	NA	NA	NA			115			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94047862,C,C&fts=all">p.R675C</a>
COL1A2	Missense_Mutation	p.P809L	C	C		7	Cancer Module	7	94052291	94052291	145	0.296551724137931	NA	NA	NA		p.P809L(1)	115			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL1A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,94052291,C,C&fts=all">p.P809L</a>
COL20A1	Nonsense_Mutation	p.W768*	G	G		7	Cancer Module	20	61945168	61945168	15	0.533333333333333	NA	NA	NA			36	Fibronectin type-III 6. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL20A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,61945168,G,G&fts=all">p.W768*</a>
COL5A1	Missense_Mutation	p.D1603N	G	G		7	Cancer Module	9	137716554	137716554	33	0.666666666666667	NA	NA	NA		p.D1603Y(1)	115	Nonhelical region.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL5A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,137716554,G,G&fts=all">p.D1603N</a>
COL9A1	Splice_Site	p.P624L	G	G		7	Cancer Module	6	70961824	70961824	164	0.365853658536585	NA	NA	NA			80	Collagen-like 6.|Triple-helical region (COL2).		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL9A1&recr=Open">Click here</a>	
COLQ	Splice_Site		C	C		7	Cancer Module	3	15493221	15493221	38	0.368421052631579	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COLQ&recr=Open">Click here</a>	
CSMD2	Missense_Mutation	p.P791S	G	G		7	Cancer Module	1	34192284	34192284	23	0.478260869565217	NA	NA	NA			246	CUB 5. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,34192284,G,G&fts=all">p.P791S</a>
CYP2C19	Missense_Mutation	p.P402S	C	C		7	Cancer Module	10	96609728	96609728	116	0.189655172413793	NA	NA	NA			43			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C19&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96609728,C,C&fts=all">p.P402S</a>
CYP2C8	Missense_Mutation	p.P174S	G	G		7	Cancer Module	10	96824679	96824679	115	0.234782608695652	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP2C8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,96824679,G,G&fts=all">p.P174S</a>
DGKE	Missense_Mutation	p.G281E	G	G		7	Cancer Module	17	54925380	54925380	94	0.574468085106383	NA	NA	NA			25	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,54925380,G,G&fts=all">p.G281E</a>
DLAT	Missense_Mutation	p.R110H	G	G		7	Cancer Module	11	111896971	111896971	87	0.0459770114942529	NA	NA	NA			22	Lipoyl-binding 1. {ECO:0000255|PROSITE- ProRule:PRU01066}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DLAT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,111896971,G,G&fts=all">p.R110H</a>
DNAH3	Missense_Mutation	p.E3758K	C	C		7	Cancer Module	16	20959876	20959876	37	0.459459459459459	NA	NA	NA			202			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,20959876,C,C&fts=all">p.E3758K</a>
DNASE1L3	Missense_Mutation	p.T173M	G	G		7	Cancer Module	3	58186752	58186752	164	0.0304878048780488	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNASE1L3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,58186752,G,G&fts=all">p.T173M</a>
DPH2	Missense_Mutation	p.R270Q	G	G	rs150291980	7	Cancer Module	1	44437383	44437383	47	0.48936170212766	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,44437383,G,G&fts=all">p.R270Q</a>
DPYSL3	Missense_Mutation	p.D34G	T	T		7	Cancer Module	5	146804465	146804465	108	0.37037037037037	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DPYSL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,146804465,T,T&fts=all">p.D34G</a>
DUSP27	Missense_Mutation	p.R901C	C	C		7	Cancer Module	1	167097069	167097069	46	0.630434782608696	NA	NA	NA		p.R901S(1)	89	Ser-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DUSP27&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,167097069,C,C&fts=all">p.R901C</a>
EML2	Splice_Site		A	A		7	Cancer Module	19	46122316	46122316	66	0.393939393939394	NA	NA	NA			31			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EML2&recr=Open">Click here</a>	
EPS15L1	Missense_Mutation	p.P101H	G	G		7	Cancer Module	19	16548588	16548588	76	0.0526315789473684	NA	NA	NA			30	EH 1. {ECO:0000255|PROSITE- ProRule:PRU00077}.|Interaction with DAB2. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPS15L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,16548588,G,G&fts=all">p.P101H</a>
FAM135B	Missense_Mutation	p.S811F	G	G		7	Cancer Module	8	139164286	139164286	67	0.343283582089552	NA	NA	NA			238			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM135B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139164286,G,G&fts=all">p.S811F</a>
FASN	Nonsense_Mutation	p.Q1200*	G	G		7	Cancer Module	17	80044264	80044264	26	0.461538461538462	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FASN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,80044264,G,G&fts=all">p.Q1200*</a>
FBLN2	Missense_Mutation	p.S437F	C	C		7	Cancer Module	3	13649565	13649565	3	0.666666666666667	NA	NA	NA			24	N.|Subdomain NB (Cys-free).		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FBLN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,13649565,C,C&fts=all">p.S437F</a>
FILIP1	Missense_Mutation	p.D198N	C	C	rs149762228	7	Cancer Module	6	76063292	76063292	203	0.344827586206897	NA	NA	NA			80			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FILIP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,76063292,C,C&fts=all">p.D198N</a>
GABRB1	Missense_Mutation	p.S396F	C	C	rs377492047	7	Cancer Module	4	47427797	47427797	57	0.263157894736842	NA	NA	NA			44			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRB1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,47427797,C,C&fts=all">p.S396F</a>
GAS2	Missense_Mutation	p.R208Q	G	G		7	Cancer Module	11	22777399	22777399	37	0.837837837837838	NA	NA	NA		p.R208Q(1)	24	GAR. {ECO:0000255|PROSITE- ProRule:PRU00792}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GAS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,22777399,G,G&fts=all">p.R208Q</a>
GPC5	Missense_Mutation	p.L332I	C	C	rs372453843	7	Cancer Module	13	92346109	92346109	60	0.383333333333333	NA	NA	NA		p.L332I(1)	69			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,92346109,C,C&fts=all">p.L332I</a>
GPRC5C	Missense_Mutation	p.V117A	T	T		7	Cancer Module	17	72436130	72436130	42	0.142857142857143	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPRC5C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72436130,T,T&fts=all">p.V117A</a>
GRIK3	Missense_Mutation	p.P715L	G	G		7	Cancer Module	1	37271875	37271875	60	0.15	NA	NA	NA			89			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRIK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,37271875,G,G&fts=all">p.P715L</a>
HCFC1	Missense_Mutation	p.S980F	G	G		7	Cancer Module	X	153220911	153220911	34	0.705882352941177	NA	NA	NA			47			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCFC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,153220911,G,G&fts=all">p.S980F</a>
HRH1	Frame_Shift_Ins	p.K261fs	-	-		7	Cancer Module	3	11301503	11301504	30	0.4	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH1&recr=Open">Click here</a>	
IL27RA	Missense_Mutation	p.P559S	C	C		7	Cancer Module	19	14162744	14162744	11	0.454545454545455	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL27RA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,14162744,C,C&fts=all">p.P559S</a>
ITGA5	Missense_Mutation	p.P884S	G	G		7	Cancer Module	12	54793725	54793725	82	0.390243902439024	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGA5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,54793725,G,G&fts=all">p.P884S</a>
KCNB2	Missense_Mutation	p.L20F	C	C		7	Cancer Module	8	73480027	73480027	107	0.327102803738318	NA	NA	NA			85			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNB2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,73480027,C,C&fts=all">p.L20F</a>
KCNJ3	Missense_Mutation	p.L264F	C	C		7	Cancer Module	2	155566202	155566202	90	0.188888888888889	NA	NA	NA			54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,155566202,C,C&fts=all">p.L264F</a>
KCNJ6	Missense_Mutation	p.E300K	C	C		7	Cancer Module	21	39086562	39086562	80	0.2625	NA	NA	NA			22			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNJ6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,21,39086562,C,C&fts=all">p.E300K</a>
KLHL18	Missense_Mutation	p.R516Q	G	G		7	Cancer Module	3	47385253	47385253	34	0.0882352941176471	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLHL18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,47385253,G,G&fts=all">p.R516Q</a>
LDB3	Missense_Mutation	p.S432F	C	C	rs397517209	7	Cancer Module	10	88476147	88476147	19	0.631578947368421	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LDB3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,88476147,C,C&fts=all">p.S432F</a>
LHCGR	Splice_Site	p.E154K	C	C		7	Cancer Module	2	48950671	48950671	45	0.466666666666667	NA	NA	NA			56			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHCGR&recr=Open">Click here</a>	
LIMK1	Nonsense_Mutation	p.Q274*	C	C		7	Cancer Module	7	73520422	73520422	132	0.484848484848485	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LIMK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,73520422,C,C&fts=all">p.Q274*</a>
LRP2	Missense_Mutation	p.R2243Q	C	C		7	Cancer Module	2	170063502	170063502	97	0.247422680412371	NA	NA	NA		p.R2243Q(1)	315			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,170063502,C,C&fts=all">p.R2243Q</a>
LTA	Missense_Mutation	p.G31R	G	G		7	Cancer Module	6	31540610	31540610	82	0.353658536585366	NA	NA	NA			9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LTA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,31540610,G,G&fts=all">p.G31R</a>
MAEA	Missense_Mutation	p.L188F	C	C		7	Cancer Module	4	1316277	1316277	70	0.428571428571429	NA	NA	NA			18	CTLH. {ECO:0000255|PROSITE- ProRule:PRU00058}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAEA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,1316277,C,C&fts=all">p.L188F</a>
MEST	Missense_Mutation	p.S119F	C	C		7	Cancer Module	7	130137996	130137996	88	0.284090909090909	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MEST&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,130137996,C,C&fts=all">p.S119F</a>
MOAP1	Missense_Mutation	p.I228V	T	T		7	Cancer Module	14	93649906	93649906	215	0.148837209302326	NA	NA	NA			13			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOAP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,93649906,T,T&fts=all">p.I228V</a>
MOBP	Missense_Mutation	p.K79N	G	G		7	Cancer Module	3	39554904	39554904	85	0.270588235294118	NA	NA	NA			6	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MOBP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,39554904,G,G&fts=all">p.K79N</a>
MPP6	Splice_Site	p.A40V	C	C		7	Cancer Module	7	24681336	24681336	80	0.1875	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP6&recr=Open">Click here</a>	
MST1R	Missense_Mutation	p.A997T	C	C		7	Cancer Module	3	49932955	49932955	56	0.303571428571429	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MST1R&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,49932955,C,C&fts=all">p.A997T</a>
MUC16	Missense_Mutation	p.S13217F	G	G		7	Cancer Module	19	9006368	9006368	87	0.218390804597701	NA	NA	NA			590	SEA 8. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9006368,G,G&fts=all">p.S13217F</a>
MUC16	Missense_Mutation	p.E7457K	C	C		7	Cancer Module	19	9065077	9065077	81	0.209876543209877	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9065077,C,C&fts=all">p.E7457K</a>
MUC16	Missense_Mutation	p.M7358I	C	C		7	Cancer Module	19	9065372	9065372	24	0.25	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,9065372,C,C&fts=all">p.M7358I</a>
MYCBP2	Missense_Mutation	p.A1667V	G	G	rs150327506	7	Cancer Module	13	77754281	77754281	34	0.205882352941176	NA	NA	NA			118			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYCBP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,77754281,G,G&fts=all">p.A1667V</a>
MYO16	Missense_Mutation	p.I1732F	A	A		7	Cancer Module	13	109817344	109817344	83	0.168674698795181	NA	NA	NA			121			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO16&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,109817344,A,A&fts=all">p.I1732F</a>
MYO1A	Missense_Mutation	p.P552S	G	G		7	Cancer Module	12	57432302	57432302	57	0.245614035087719	NA	NA	NA			50	Myosin motor.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,57432302,G,G&fts=all">p.P552S</a>
NAT1	Missense_Mutation	p.S274F	C	C		7	Cancer Module	8	18080377	18080377	57	0.157894736842105	NA	NA	NA			9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NAT1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,18080377,C,C&fts=all">p.S274F</a>
NINJ1	Copy Number	Deleted	NA	NA	NA	7	Cancer Module	9	95610835	95888922	NA	NA	25	-1.62905458742336	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NINJ1&recr=Open">Click here</a>	
NRP2	Missense_Mutation	p.D909N	G	G		7	Cancer Module	2	206659726	206659726	28	0.285714285714286	NA	NA	NA			52			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NRP2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,206659726,G,G&fts=all">p.D909N</a>
OR2F1	Missense_Mutation	p.P93S	C	C		7	Cancer Module	7	143657340	143657340	122	0.377049180327869	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2F1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,143657340,C,C&fts=all">p.P93S</a>
P2RY10	Missense_Mutation	p.D149N	G	G		7	Cancer Module	X	78216462	78216462	43	0.744186046511628	NA	NA	NA			42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+P2RY10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,78216462,G,G&fts=all">p.D149N</a>
PCLO	Missense_Mutation	p.M964I	C	C	rs267601599	7	Cancer Module	7	82763974	82763974	47	0.297872340425532	NA	NA	NA			259			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCLO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,82763974,C,C&fts=all">p.M964I</a>
PLA2R1	Missense_Mutation	p.S1110F	G	G		7	Cancer Module	2	160808062	160808062	66	0.166666666666667	NA	NA	NA			60			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLA2R1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,160808062,G,G&fts=all">p.S1110F</a>
PLXDC2	Missense_Mutation	p.R254Q	G	G		7	Cancer Module	10	20436809	20436809	35	0.257142857142857	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXDC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,20436809,G,G&fts=all">p.R254Q</a>
POLDIP3	Missense_Mutation	p.P390S	G	G		7	Cancer Module	22	42981895	42981895	71	0.408450704225352	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLDIP3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,42981895,G,G&fts=all">p.P390S</a>
POLG	Missense_Mutation	p.P340S	G	G		7	Cancer Module	15	89872179	89872179	38	0.157894736842105	NA	NA	NA			33			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,89872179,G,G&fts=all">p.P340S</a>
PPFIA2	Missense_Mutation	p.C921W	G	G		7	Cancer Module	12	81688776	81688776	35	0.2	NA	NA	NA			85	SAM 1. {ECO:0000255|PROSITE- ProRule:PRU00184}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPFIA2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,81688776,G,G&fts=all">p.C921W</a>
PPP1R15A	Frame_Shift_Ins	p.E443fs	-	-		7	Cancer Module	19	49377815	49377816	96	0.166666666666667	NA	NA	NA			23	4 X 34 AA approximate repeats.|Glu-rich.|Interaction with SMAD7.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PPP1R15A&recr=Open">Click here</a>	
PRDM10	Missense_Mutation	p.R288W	G	G		7	Cancer Module	11	129812425	129812425	98	0.0408163265306122	NA	NA	NA			48	SET. {ECO:0000255|PROSITE- ProRule:PRU00190}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,129812425,G,G&fts=all">p.R288W</a>
PRKG2	Missense_Mutation	p.G320E	C	C		7	Cancer Module	4	82074829	82074829	95	0.421052631578947	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKG2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,82074829,C,C&fts=all">p.G320E</a>
PTPRT	Missense_Mutation	p.R1090L	C	C		7	Cancer Module	20	40735547	40735547	31	0.225806451612903	NA	NA	NA			176	Substrate binding. {ECO:0000250}.|Tyrosine-protein phosphatase 1. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRT&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,40735547,C,C&fts=all">p.R1090L</a>
PTPRU	Missense_Mutation	p.D1267N	G	G		7	Cancer Module	1	29647278	29647278	27	0.333333333333333	NA	NA	NA			79	Tyrosine-protein phosphatase 2. {ECO:0000255|PROSITE-ProRule:PRU00160}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTPRU&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,29647278,G,G&fts=all">p.D1267N</a>
RBBP6	Nonsense_Mutation	p.Q1079*	C	C		7	Cancer Module	16	24581246	24581246	63	0.174603174603175	NA	NA	NA			46	Interaction with RB1. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBBP6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,24581246,C,C&fts=all">p.Q1079*</a>
RGS9	Missense_Mutation	p.D649N	G	G		7	Cancer Module	17	63223445	63223445	89	0.460674157303371	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,63223445,G,G&fts=all">p.D649N</a>
RP1	Missense_Mutation	p.N760I	A	A		7	Cancer Module	8	55538721	55538721	117	0.358974358974359	NA	NA	NA			169			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55538721,A,A&fts=all">p.N760I</a>
RP1	Missense_Mutation	p.M1203I	G	G		7	Cancer Module	8	55540051	55540051	124	0.419354838709677	NA	NA	NA			169			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,55540051,G,G&fts=all">p.M1203I</a>
RTN1	Missense_Mutation	p.G102R	C	C		7	Cancer Module	14	60213137	60213137	59	0.288135593220339	NA	NA	NA			49			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RTN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,60213137,C,C&fts=all">p.G102R</a>
RYR1	Splice_Site	p.V1850M	G	G		7	Cancer Module	19	38979817	38979817	30	0.333333333333333	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Missense_Mutation	p.R2806C	C	C		7	Cancer Module	19	38996461	38996461	33	0.303030303030303	NA	NA	NA			285	6 X approximate repeats.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,38996461,C,C&fts=all">p.R2806C</a>
SCN4A	Missense_Mutation	p.E1606K	C	C		7	Cancer Module	17	62018826	62018826	70	0.371428571428571	NA	NA	NA			101			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN4A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,62018826,C,C&fts=all">p.E1606K</a>
SCN9A	Missense_Mutation	p.S1713N	C	C	rs200266625	7	Cancer Module	2	167055978	167055978	156	0.480769230769231	NA	NA	NA			108			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167055978,C,C&fts=all">p.S1713N</a>
SCN9A	Missense_Mutation	p.D1499N	C	C		7	Cancer Module	2	167060711	167060711	72	0.236111111111111	NA	NA	NA			108			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN9A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,167060711,C,C&fts=all">p.D1499N</a>
SCYL3	Missense_Mutation	p.K430T	T	T		7	Cancer Module	1	169828205	169828205	130	0.184615384615385	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCYL3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,169828205,T,T&fts=all">p.K430T</a>
SIGLEC5	Nonsense_Mutation	p.Q502*	G	G		7	Cancer Module	19	52115636	52115636	64	0.34375	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIGLEC5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52115636,G,G&fts=all">p.Q502*</a>
SLC24A3	Missense_Mutation	p.S625F	C	C		7	Cancer Module	20	19701723	19701723	100	0.29	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC24A3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,19701723,C,C&fts=all">p.S625F</a>
SLC5A4	Missense_Mutation	p.A644T	C	C	rs372331398	7	Cancer Module	22	32614551	32614551	106	0.179245283018868	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC5A4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,22,32614551,C,C&fts=all">p.A644T</a>
SLITRK1	Missense_Mutation	p.E254K	C	C		7	Cancer Module	13	84454883	84454883	42	0.595238095238095	NA	NA	NA		p.E254*(1)	80	LRRCT 1.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLITRK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,84454883,C,C&fts=all">p.E254K</a>
SORBS2	Missense_Mutation	p.G702D	C	C		7	Cancer Module	4	186533085	186533085	59	0.23728813559322	NA	NA	NA			53			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORBS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,186533085,C,C&fts=all">p.G702D</a>
SOX30	Missense_Mutation	p.E745K	C	C		7	Cancer Module	5	157053377	157053377	129	0.27906976744186	NA	NA	NA			23			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOX30&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,157053377,C,C&fts=all">p.E745K</a>
SPTA1	Missense_Mutation	p.E1283K	C	C		7	Cancer Module	1	158617378	158617378	65	0.661538461538462	NA	NA	NA			307			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,158617378,C,C&fts=all">p.E1283K</a>
ST18	Missense_Mutation	p.R256K	C	C		7	Cancer Module	8	53084654	53084654	83	0.457831325301205	NA	NA	NA			85			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,53084654,C,C&fts=all">p.R256K</a>
STON2	Missense_Mutation	p.P230S	G	G		7	Cancer Module	14	81744967	81744967	34	0.647058823529412	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,81744967,G,G&fts=all">p.P230S</a>
TACC2	Missense_Mutation	p.S1485F	C	C		7	Cancer Module	10	123846469	123846469	18	0.222222222222222	NA	NA	NA			83			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,123846469,C,C&fts=all">p.S1485F</a>
TBC1D8B	Nonsense_Mutation	p.Q1014*	C	C		7	Cancer Module	X	106116872	106116872	53	0.735849056603774	NA	NA	NA			47			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D8B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,106116872,C,C&fts=all">p.Q1014*</a>
TGM7	Missense_Mutation	p.P394L	G	G		7	Cancer Module	15	43574212	43574212	22	0.227272727272727	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,43574212,G,G&fts=all">p.P394L</a>
TLL2	Missense_Mutation	p.R221Q	C	C	rs371145521	7	Cancer Module	10	98182461	98182461	57	0.385964912280702	NA	NA	NA			58	Metalloprotease. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TLL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,98182461,C,C&fts=all">p.R221Q</a>
TPO	Missense_Mutation	p.G860E	G	G		7	Cancer Module	2	1520715	1520715	40	0.2	NA	NA	NA		p.G860E(1)	95			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPO&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,1520715,G,G&fts=all">p.G860E</a>
TREM1	Missense_Mutation	p.P155S	G	G		7	Cancer Module	6	41248835	41248835	66	0.227272727272727	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TREM1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,41248835,G,G&fts=all">p.P155S</a>
TTN	Missense_Mutation	p.R6703Q	C	C	rs546821182	7	Cancer Module	2	179591984	179591984	49	0.428571428571429	NA	NA	NA			1448	Ig-like 48.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179591984,C,C&fts=all">p.R6703Q</a>
TTN	Missense_Mutation	p.P5075S	G	G		7	Cancer Module	2	179599328	179599328	98	0.26530612244898	NA	NA	NA			1448	Ig-like 31.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,179599328,G,G&fts=all">p.P5075S</a>
TTYH2	Missense_Mutation	p.A93T	G	G		7	Cancer Module	17	72218771	72218771	59	0.525423728813559	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,72218771,G,G&fts=all">p.A93T</a>
WDR60	In_Frame_Del	p.LCSF588del	TTATGTAGCTTT	TTATGTAGCTTT		7	Cancer Module	7	158706983	158706994	46	0.152173913043478	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR60&recr=Open">Click here</a>	
ZEB2	Copy Number	Amplified	NA	NA	NA	7	Cancer Module	2	144899624	145274919	NA	NA	13	3.49284020316407	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZEB2&recr=Open">Click here</a>	
ZNF655	Nonsense_Mutation	p.Q16*	C	C		7	Cancer Module	7	99158228	99158228	117	0.478632478632479	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF655&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,99158228,C,C&fts=all">p.Q16*</a>
HKDC1	Missense_Mutation	p.E271K	G	G		7.75	Cancer Gene	10	71003057	71003057	67	0.17910447761194	NA	NA	NA			34	Hexokinase type-2 1.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HKDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,71003057,G,G&fts=all">p.E271K</a>
HKDC1	Missense_Mutation	p.S745N	G	G		7.75	Cancer Gene	10	71020912	71020912	76	0.144736842105263	NA	NA	NA			34	Hexokinase type-2 2.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HKDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,71020912,G,G&fts=all">p.S745N</a>
ADAM18	Missense_Mutation	p.S132F	C	C		8	Cancer Gene	8	39468098	39468098	103	0.504854368932039	NA	NA	NA			71			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,39468098,C,C&fts=all">p.S132F</a>
ADAM22	Missense_Mutation	p.E457K	G	G		8	Cancer Gene	7	87774488	87774488	118	0.576271186440678	NA	NA	NA			53	Disintegrin. {ECO:0000255|PROSITE- ProRule:PRU00068}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,87774488,G,G&fts=all">p.E457K</a>
ALDH16A1	Missense_Mutation	p.V100I	G	G		8	Cancer Gene	19	49962321	49962321	52	0.0769230769230769	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALDH16A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49962321,G,G&fts=all">p.V100I</a>
ALLC	Missense_Mutation	p.R176Q	G	G		8	Cancer Gene	2	3743322	3743322	47	0.25531914893617	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ALLC&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,3743322,G,G&fts=all">p.R176Q</a>
ARHGAP39	Missense_Mutation	p.G862E	C	C		8	Cancer Gene	8	145759523	145759523	71	0.323943661971831	NA	NA	NA			22	MyTH4. {ECO:0000255|PROSITE- ProRule:PRU00359}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,145759523,C,C&fts=all">p.G862E</a>
B3GAT1	Splice_Site		C	C		8	Cancer Gene	11	134251919	134251919	31	0.741935483870968	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+B3GAT1&recr=Open">Click here</a>	
C10orf68	Missense_Mutation	p.R473C	C	C		8	Cancer Gene	10	33137562	33137562	101	0.0396039603960396	NA	NA	NA		p.R514C(1)	29			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf68&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,33137562,C,C&fts=all">p.R473C</a>
C1QL2	Missense_Mutation	p.G265S	C	C		8	Cancer Gene	2	119914449	119914449	72	0.152777777777778	NA	NA	NA			7	C1q. {ECO:0000255|PROSITE- ProRule:PRU00368}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,119914449,C,C&fts=all">p.G265S</a>
C1orf173	Missense_Mutation	p.N1373K	A	A		8	Cancer Gene	1	75037275	75037275	95	0.221052631578947	NA	NA	NA			184	Glu-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1orf173&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,75037275,A,A&fts=all">p.N1373K</a>
C2orf78	Missense_Mutation	p.D676N	G	G	rs376095330	8	Cancer Gene	2	74043376	74043376	37	0.27027027027027	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C2orf78&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74043376,G,G&fts=all">p.D676N</a>
C9orf89	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	95610835	95888922	NA	NA	25	-1.62905458742336	TRUE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C9orf89&recr=Open">Click here</a>	
CAMK1D	Missense_Mutation	p.R298Q	G	G	rs201893185	8	Cancer Gene	10	12866523	12866523	18	0.222222222222222	NA	NA	NA		p.R298Q(2)	16	Autoinhibitory domain. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMK1D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,12866523,G,G&fts=all">p.R298Q</a>
CAMTA1	Missense_Mutation	p.G298E	G	G		8	Cancer Gene	1	7723500	7723500	95	0.547368421052632	NA	NA	NA			85			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAMTA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,7723500,G,G&fts=all">p.G298E</a>
CCDC39	Missense_Mutation	p.R51Q	C	C		8	Cancer Gene	3	180381713	180381713	126	0.5	NA	NA	NA			45			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC39&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,180381713,C,C&fts=all">p.R51Q</a>
CCDC73	Missense_Mutation	p.R198K	C	C		8	Cancer Gene	11	32697163	32697163	102	0.705882352941177	NA	NA	NA			51			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC73&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,32697163,C,C&fts=all">p.R198K</a>
CCL3L3	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	34590456	34641539	NA	NA	6	-1.07491204512002	TRUE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL3L3&recr=Open">Click here</a>	
CCL4L1	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	34590456	34641539	NA	NA	6	-1.07491204512002	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL4L1&recr=Open">Click here</a>	
CCL4L2	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	34590456	34641539	NA	NA	6	-1.07491204512002	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL4L2&recr=Open">Click here</a>	
CEP152	Missense_Mutation	p.L769V	G	G		8	Cancer Gene	15	49054845	49054845	107	0.149532710280374	NA	NA	NA			63			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP152&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,49054845,G,G&fts=all">p.L769V</a>
CEP70	Missense_Mutation	p.E431K	C	C		8	Cancer Gene	3	138219654	138219654	89	0.640449438202247	NA	NA	NA			24			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CEP70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,138219654,C,C&fts=all">p.E431K</a>
CLEC1A	Missense_Mutation	p.S24C	G	G		8	Cancer Gene	12	10251451	10251451	28	0.321428571428571	NA	NA	NA			23			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC1A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10251451,G,G&fts=all">p.S24C</a>
CLEC4F	Missense_Mutation	p.G143E	C	C		8	Cancer Gene	2	71044085	71044085	97	0.412371134020619	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC4F&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,71044085,C,C&fts=all">p.G143E</a>
COL14A1	Missense_Mutation	p.G1471R	G	G		8	Cancer Gene	8	121322257	121322257	107	0.214953271028037	NA	NA	NA			119			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL14A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,121322257,G,G&fts=all">p.G1471R</a>
COL22A1	Missense_Mutation	p.R327L	C	C		8	Cancer Gene	8	139833644	139833644	103	0.12621359223301	NA	NA	NA			211	Laminin G-like.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL22A1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,139833644,C,C&fts=all">p.R327L</a>
CSMD1	Missense_Mutation	p.R1810Q	C	C		8	Cancer Gene	8	3046506	3046506	32	0.3125	NA	NA	NA		p.R1538Q(1)|p.R1809Q(1)	25	CUB 11. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,3046506,C,C&fts=all">p.R1810Q</a>
CTDSP1	Missense_Mutation	p.K32E	A	A		8	Cancer Gene	2	219266313	219266313	58	0.413793103448276	NA	NA	NA			8			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTDSP1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,219266313,A,A&fts=all">p.K32E</a>
CYP4F22	Missense_Mutation	p.P102H	C	C		8	Cancer Gene	19	15640602	15640602	35	0.428571428571429	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4F22&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,15640602,C,C&fts=all">p.P102H</a>
CYP4X1	Missense_Mutation	p.H158Y	C	C		8	Cancer Gene	1	47499020	47499020	123	0.447154471544715	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CYP4X1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,47499020,C,C&fts=all">p.H158Y</a>
DCAF8L1	Missense_Mutation	p.D319N	C	C		8	Cancer Gene	X	27998497	27998497	48	0.604166666666667	NA	NA	NA			56			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DCAF8L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,27998497,C,C&fts=all">p.D319N</a>
DEFB114	Missense_Mutation	p.R28C	G	G		8	Cancer Gene	6	49928133	49928133	113	0.36283185840708	NA	NA	NA		p.R28C(1)	8			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DEFB114&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,49928133,G,G&fts=all">p.R28C</a>
DGKH	Missense_Mutation	p.F349L	T	T		8	Cancer Gene	13	42740737	42740737	141	0.283687943262411	NA	NA	NA			43	DAGKc. {ECO:0000255|PROSITE- ProRule:PRU00783}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKH&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,13,42740737,T,T&fts=all">p.F349L</a>
DKKL1	Missense_Mutation	p.R142K	G	G	rs368784520	8	Cancer Gene	19	49877981	49877981	51	0.313725490196078	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DKKL1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,49877981,G,G&fts=all">p.R142K</a>
ELOVL4	Nonsense_Mutation	p.W246*	C	C		8	Cancer Gene	6	80626533	80626533	162	0.462962962962963	NA	NA	NA			22			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ELOVL4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,80626533,C,C&fts=all">p.W246*</a>
FAM13C	Missense_Mutation	p.R427Q	C	C		8	Cancer Gene	10	61014160	61014160	106	0.471698113207547	NA	NA	NA			45			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM13C&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,61014160,C,C&fts=all">p.R427Q</a>
FAT3	Missense_Mutation	p.P188L	C	C		8	Cancer Gene	11	92086291	92086291	18	0.777777777777778	NA	NA	NA			85	Cadherin 2. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,92086291,C,C&fts=all">p.P188L</a>
FGD3	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	95610835	95888922	NA	NA	25	-1.62905458742336	TRUE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD3&recr=Open">Click here</a>	
FGD5	Missense_Mutation	p.P408L	C	C		8	Cancer Gene	3	14861801	14861801	36	0.361111111111111	NA	NA	NA			54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,14861801,C,C&fts=all">p.P408L</a>
FLG	Missense_Mutation	p.G2499E	C	C		8	Cancer Gene	1	152279866	152279866	143	0.629370629370629	NA	NA	NA			424	Ser-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FLG&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,152279866,C,C&fts=all">p.G2499E</a>
FMN2	Missense_Mutation	p.T457A	A	A		8	Cancer Gene	1	240256778	240256778	16	0.625	NA	NA	NA			178			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FMN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,240256778,A,A&fts=all">p.T457A</a>
FNDC1	Missense_Mutation	p.S603F	C	C		8	Cancer Gene	6	159653352	159653352	14	0.5	NA	NA	NA			93			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FNDC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,159653352,C,C&fts=all">p.S603F</a>
FPR3	Missense_Mutation	p.T23I	C	C		8	Cancer Gene	19	52327069	52327069	54	0.37037037037037	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FPR3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,52327069,C,C&fts=all">p.T23I</a>
FRAS1	Missense_Mutation	p.R2590C	C	C	rs368735572	8	Cancer Gene	4	79396677	79396677	53	0.566037735849057	NA	NA	NA			103	Calx-beta 1.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRAS1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,79396677,C,C&fts=all">p.R2590C</a>
GABRG1	Missense_Mutation	p.G33E	C	C		8	Cancer Gene	4	46125833	46125833	80	0.2875	NA	NA	NA			76			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRG1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,46125833,C,C&fts=all">p.G33E</a>
GCN1L1	Splice_Site	p.Q563*	G	G		8	Cancer Gene	12	120602451	120602451	72	0.444444444444444	NA	NA	NA			94			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GCN1L1&recr=Open">Click here</a>	
GET4	Missense_Mutation	p.M87V	A	A		8	Cancer Gene	7	926230	926230	122	0.245901639344262	NA	NA	NA			11			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GET4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,926230,A,A&fts=all">p.M87V</a>
GFRAL	Missense_Mutation	p.D230E	T	T		8	Cancer Gene	6	55216370	55216370	40	0.3	NA	NA	NA			48			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GFRAL&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,55216370,T,T&fts=all">p.D230E</a>
GHSR	Missense_Mutation	p.D89N	C	C		8	Cancer Gene	3	172165939	172165939	13	0.384615384615385	NA	NA	NA			33			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GHSR&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,172165939,C,C&fts=all">p.D89N</a>
GPR63	Missense_Mutation	p.E414K	C	C	rs142431486	8	Cancer Gene	6	97246368	97246368	107	0.476635514018692	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPR63&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,97246368,C,C&fts=all">p.E414K</a>
GTDC1	Copy Number	Amplified	NA	NA	NA	8	Cancer Gene	2	144194613	144765104	NA	NA	13	3.75550719359018	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTDC1&recr=Open">Click here</a>	
GTDC1	Copy Number	Amplified	NA	NA	NA	8	Cancer Gene	2	144899624	145274919	NA	NA	13	3.49284020316407	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GTDC1&recr=Open">Click here</a>	
HECW2	Missense_Mutation	p.S17F	G	G		8	Cancer Gene	2	197184496	197184496	65	0.246153846153846	NA	NA	NA			113			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HECW2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,197184496,G,G&fts=all">p.S17F</a>
HIPK3	Missense_Mutation	p.I625V	A	A		8	Cancer Gene	11	33363208	33363208	141	0.0283687943262411	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIPK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,33363208,A,A&fts=all">p.I625V</a>
HMCN1	Missense_Mutation	p.D3357G	A	A		8	Cancer Gene	1	186062675	186062675	100	0.66	NA	NA	NA			308	Ig-like C2-type 32.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMCN1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,186062675,A,A&fts=all">p.D3357G</a>
HMX2	Missense_Mutation	p.S114L	C	C		8	Cancer Gene	10	124909158	124909158	32	0.3125	NA	NA	NA			7			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMX2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,124909158,C,C&fts=all">p.S114L</a>
HORMAD1	Missense_Mutation	p.E206K	C	C		8	Cancer Gene	1	150679217	150679217	114	0.649122807017544	NA	NA	NA			16	HORMA. {ECO:0000255|PROSITE- ProRule:PRU00109}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HORMAD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,150679217,C,C&fts=all">p.E206K</a>
HTR3B	Missense_Mutation	p.F273L	C	C		8	Cancer Gene	11	113813826	113813826	42	0.714285714285714	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR3B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,113813826,C,C&fts=all">p.F273L</a>
IL18RAP	Missense_Mutation	p.G305R	G	G		8	Cancer Gene	2	103067436	103067436	95	0.463157894736842	NA	NA	NA			37	Ig-like C2-type 2.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL18RAP&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,103067436,G,G&fts=all">p.G305R</a>
IQCA1	Missense_Mutation	p.R69Q	C	C	rs372732894	8	Cancer Gene	2	237405936	237405936	23	0.434782608695652	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,237405936,C,C&fts=all">p.R69Q</a>
ITIH5	Missense_Mutation	p.E131K	C	C		8	Cancer Gene	10	7682727	7682727	40	0.3	NA	NA	NA			75	VIT. {ECO:0000255|PROSITE- ProRule:PRU00801}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,7682727,C,C&fts=all">p.E131K</a>
JPH1	Missense_Mutation	p.P539S	G	G		8	Cancer Gene	8	75157054	75157054	51	0.431372549019608	NA	NA	NA			24			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+JPH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,75157054,G,G&fts=all">p.P539S</a>
KCNIP4	Missense_Mutation	p.M8I	C	C		8	Cancer Gene	4	21305506	21305506	93	0.268817204301075	NA	NA	NA			13	KIS. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KCNIP4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,21305506,C,C&fts=all">p.M8I</a>
KDM4D	Missense_Mutation	p.R326H	G	G		8	Cancer Gene	11	94731513	94731513	46	0.0652173913043478	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KDM4D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,94731513,G,G&fts=all">p.R326H</a>
LAIR2	Missense_Mutation	p.G94E	G	G		8	Cancer Gene	19	55019316	55019316	56	0.267857142857143	NA	NA	NA			18	Ig-like C2-type.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAIR2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,55019316,G,G&fts=all">p.G94E</a>
LMLN	Missense_Mutation	p.T220I	C	C		8	Cancer Gene	3	197707306	197707306	87	0.609195402298851	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMLN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,197707306,C,C&fts=all">p.T220I</a>
LRFN2	Missense_Mutation	p.P745S	G	G		8	Cancer Gene	6	40359819	40359819	39	0.230769230769231	NA	NA	NA			58			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRFN2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,40359819,G,G&fts=all">p.P745S</a>
MACC1	Nonsense_Mutation	p.W363*	C	C		8	Cancer Gene	7	20198895	20198895	134	0.514925373134328	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MACC1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,20198895,C,C&fts=all">p.W363*</a>
MAGEA12	Missense_Mutation	p.S300F	G	G	rs376772901	8	Cancer Gene	X	151899902	151899902	92	0.793478260869565	NA	NA	NA			28	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,X,151899902,G,G&fts=all">p.S300F</a>
MAP3K9	Missense_Mutation	p.G490E	C	C		8	Cancer Gene	14	71199816	71199816	23	0.173913043478261	NA	NA	NA			46			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAP3K9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,71199816,C,C&fts=all">p.G490E</a>
MFSD5	Missense_Mutation	p.D227E	C	C		8	Cancer Gene	12	53647300	53647300	67	0.17910447761194	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MFSD5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,53647300,C,C&fts=all">p.D227E</a>
MPP7	Missense_Mutation	p.R362Q	C	C	rs374117925	8	Cancer Gene	10	28378638	28378638	146	0.321917808219178	NA	NA	NA			22			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPP7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,28378638,C,C&fts=all">p.R362Q</a>
MUC21	Missense_Mutation	p.G78E	G	G		8	Cancer Gene	6	30955865	30955865	62	0.451612903225806	NA	NA	NA			42	28 X 15 AA approximate tandem repeats.|Ser-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC21&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,30955865,G,G&fts=all">p.G78E</a>
MUC7	Missense_Mutation	p.P49S	C	C	rs144200604	8	Cancer Gene	4	71346606	71346606	110	0.281818181818182	NA	NA	NA			42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,71346606,C,C&fts=all">p.P49S</a>
MYOF	Missense_Mutation	p.E1743K	C	C		8	Cancer Gene	10	95085627	95085627	83	0.506024096385542	NA	NA	NA			67			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYOF&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,95085627,C,C&fts=all">p.E1743K</a>
NETO1	Missense_Mutation	p.G181E	C	C		8	Cancer Gene	18	70461449	70461449	49	0.510204081632653	NA	NA	NA			63	CUB 2. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NETO1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,18,70461449,C,C&fts=all">p.G181E</a>
OBSCN	Missense_Mutation	p.A988T	G	G		8	Cancer Gene	1	228412192	228412192	35	0.0857142857142857	NA	NA	NA			223	Ig-like 10.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OBSCN&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,228412192,G,G&fts=all">p.A988T</a>
OR2B6	Missense_Mutation	p.S217L	C	C	rs200986280	8	Cancer Gene	6	27925668	27925668	162	0.271604938271605	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2B6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,27925668,C,C&fts=all">p.S217L</a>
OR4M2	Missense_Mutation	p.M136I	G	G		8	Cancer Gene	15	22368983	22368983	245	0.0816326530612245	NA	NA	NA			63			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR4M2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,22368983,G,G&fts=all">p.M136I</a>
OSBPL7	Splice_Site	p.D601V	T	T	rs192092778	8	Cancer Gene	17	45888038	45888038	28	0.571428571428571	NA	NA	NA			32			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OSBPL7&recr=Open">Click here</a>	
PCDH15	Missense_Mutation	p.S1836L	G	G		8	Cancer Gene	10	55581985	55581985	71	0.267605633802817	NA	NA	NA			237			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH15&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,55581985,G,G&fts=all">p.S1836L</a>
PCDH18	Missense_Mutation	p.G331E	C	C		8	Cancer Gene	4	138451591	138451591	128	0.40625	NA	NA	NA			86	Cadherin 3. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDH18&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,138451591,C,C&fts=all">p.G331E</a>
PKHD1L1	Missense_Mutation	p.A3562V	C	C		8	Cancer Gene	8	110510776	110510776	89	0.50561797752809	NA	NA	NA			263			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PKHD1L1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,110510776,C,C&fts=all">p.A3562V</a>
PLEKHH1	Missense_Mutation	p.P321S	C	C		8	Cancer Gene	14	68029309	68029309	13	0.230769230769231	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHH1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,68029309,C,C&fts=all">p.P321S</a>
PNPLA1	Missense_Mutation	p.P67S	C	C	rs375531508	8	Cancer Gene	6	36260883	36260883	97	0.0412371134020619	NA	NA	NA			22	Patatin.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PNPLA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,36260883,C,C&fts=all">p.P67S</a>
POPDC3	Missense_Mutation	p.R287Q	C	C	rs138128513	8	Cancer Gene	6	105606361	105606361	94	0.606382978723404	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POPDC3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,6,105606361,C,C&fts=all">p.R287Q</a>
PRDM5	Nonsense_Mutation	p.Q405*	G	G		8	Cancer Gene	4	121706222	121706222	91	0.43956043956044	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRDM5&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,121706222,G,G&fts=all">p.Q405*</a>
PSG4	Missense_Mutation	p.N61S	T	T		8	Cancer Gene	19	43708286	43708286	119	0.235294117647059	NA	NA	NA			24	Ig-like V-type.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSG4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,43708286,T,T&fts=all">p.N61S</a>
RALGAPB	Missense_Mutation	p.R757H	G	G	rs376931767	8	Cancer Gene	20	37163753	37163753	157	0.0318471337579618	NA	NA	NA			65			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RALGAPB&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,37163753,G,G&fts=all">p.R757H</a>
RGMA	Missense_Mutation	p.A100V	G	G		8	Cancer Gene	15	93595242	93595242	13	0.461538461538462	NA	NA	NA			9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGMA&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,93595242,G,G&fts=all">p.A100V</a>
RNF121	Missense_Mutation	p.M8I	G	G		8	Cancer Gene	11	71671814	71671814	46	0.282608695652174	NA	NA	NA			13			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF121&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,71671814,G,G&fts=all">p.M8I</a>
SCN11A	Missense_Mutation	p.E1636K	C	C		8	Cancer Gene	3	38888655	38888655	140	0.342857142857143	NA	NA	NA			119			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38888655,C,C&fts=all">p.E1636K</a>
SCN11A	Missense_Mutation	p.E775K	C	C		8	Cancer Gene	3	38938416	38938416	84	0.321428571428571	NA	NA	NA			119			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,38938416,C,C&fts=all">p.E775K</a>
SCN3A	Missense_Mutation	p.D1089N	C	C		8	Cancer Gene	2	165984269	165984269	113	0.442477876106195	NA	NA	NA			120			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN3A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,165984269,C,C&fts=all">p.D1089N</a>
SEMA6D	Missense_Mutation	p.F291L	T	T		8	Cancer Gene	15	48056172	48056172	73	0.465753424657534	NA	NA	NA			77	Sema. {ECO:0000255|PROSITE- ProRule:PRU00352}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SEMA6D&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,48056172,T,T&fts=all">p.F291L</a>
SH3TC2	Missense_Mutation	p.S214F	G	G		8	Cancer Gene	5	148421048	148421048	37	0.405405405405405	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SH3TC2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,148421048,G,G&fts=all">p.S214F</a>
SIRT2	Missense_Mutation	p.A358V	G	G	rs200516283	8	Cancer Gene	19	39369892	39369892	43	0.162790697674419	NA	NA	NA			9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SIRT2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,39369892,G,G&fts=all">p.A358V</a>
SLC12A9	Missense_Mutation	p.G101R	G	G		8	Cancer Gene	7	100452361	100452361	89	0.438202247191011	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A9&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,100452361,G,G&fts=all">p.G101R</a>
SLC16A12	Missense_Mutation	p.G117E	C	C		8	Cancer Gene	10	91200963	91200963	69	0.521739130434783	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC16A12&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,91200963,C,C&fts=all">p.G117E</a>
SLC27A6	Missense_Mutation	p.G521E	G	G		8	Cancer Gene	5	128365279	128365279	111	0.342342342342342	NA	NA	NA			44			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC27A6&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,128365279,G,G&fts=all">p.G521E</a>
SLC28A2	Missense_Mutation	p.A335V	C	C	rs200711174	8	Cancer Gene	15	45559714	45559714	81	0.0493827160493827	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC28A2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,15,45559714,C,C&fts=all">p.A335V</a>
SLFN13	Missense_Mutation	p.D120N	C	C		8	Cancer Gene	17	33772342	33772342	76	0.644736842105263	NA	NA	NA			31			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLFN13&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,17,33772342,C,C&fts=all">p.D120N</a>
SLX4	Missense_Mutation	p.A455T	C	C		8	Cancer Gene	16	3647801	3647801	57	0.0701754385964912	NA	NA	NA			76	Interaction with SLX4IP, ERCC4 and MSH2.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLX4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,16,3647801,C,C&fts=all">p.A455T</a>
SORCS2	Missense_Mutation	p.S967F	C	C		8	Cancer Gene	4	7730107	7730107	23	0.391304347826087	NA	NA	NA			42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,7730107,C,C&fts=all">p.S967F</a>
SORCS3	Missense_Mutation	p.E1175K	G	G		8	Cancer Gene	10	107022168	107022168	53	0.358490566037736	NA	NA	NA		p.E1175K(1)	131			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,107022168,G,G&fts=all">p.E1175K</a>
ST6GAL2	Missense_Mutation	p.A369T	C	C		8	Cancer Gene	2	107449059	107449059	63	0.349206349206349	NA	NA	NA			65			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ST6GAL2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,107449059,C,C&fts=all">p.A369T</a>
STXBP5L	Missense_Mutation	p.P404S	C	C		8	Cancer Gene	3	120957843	120957843	70	0.5	NA	NA	NA			68			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STXBP5L&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,120957843,C,C&fts=all">p.P404S</a>
SUSD3	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	95610835	95888922	NA	NA	25	-1.62905458742336	TRUE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SUSD3&recr=Open">Click here</a>	
SYT10	Missense_Mutation	p.I395N	A	A		8	Cancer Gene	12	33538120	33538120	100	0.37	NA	NA	NA			42	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT10&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,33538120,A,A&fts=all">p.I395N</a>
TAOK3	Missense_Mutation	p.G345S	C	C		8	Cancer Gene	12	118637017	118637017	46	0.239130434782609	NA	NA	NA			7	Ser-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAOK3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,118637017,C,C&fts=all">p.G345S</a>
TAS1R3	Missense_Mutation	p.D34N	G	G		8	Cancer Gene	1	1266825	1266825	16	0.25	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS1R3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,1266825,G,G&fts=all">p.D34N</a>
TAS2R7	Missense_Mutation	p.L206F	G	G		8	Cancer Gene	12	10954554	10954554	18	0.222222222222222	NA	NA	NA			10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R7&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,10954554,G,G&fts=all">p.L206F</a>
TBC1D3C	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	17	34590456	34641539	NA	NA	6	-1.07491204512002	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TBC1D3C&recr=Open">Click here</a>	
TC2N	Missense_Mutation	p.S50F	G	G		8	Cancer Gene	14	92278808	92278808	109	0.119266055045872	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TC2N&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,92278808,G,G&fts=all">p.S50F</a>
TET3	Missense_Mutation	p.P970S	C	C		8	Cancer Gene	2	74326448	74326448	11	0.363636363636364	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TET3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,74326448,C,C&fts=all">p.P970S</a>
TMEM215	Missense_Mutation	p.G169S	G	G		8	Cancer Gene	9	32784686	32784686	22	0.590909090909091	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMEM215&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,32784686,G,G&fts=all">p.G169S</a>
TMPRSS11A	Missense_Mutation	p.G170E	C	C	rs144009146	8	Cancer Gene	4	68789866	68789866	142	0.408450704225352	NA	NA	NA			29			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,68789866,C,C&fts=all">p.G170E</a>
TMPRSS11B	Missense_Mutation	p.P121L	G	G		8	Cancer Gene	4	69100288	69100288	100	0.21	NA	NA	NA			27	SEA. {ECO:0000255|PROSITE- ProRule:PRU00188}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMPRSS11B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,69100288,G,G&fts=all">p.P121L</a>
TRANK1	Missense_Mutation	p.D886N	C	C		8	Cancer Gene	3	36896775	36896775	84	0.238095238095238	NA	NA	NA			73			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRANK1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,36896775,C,C&fts=all">p.D886N</a>
TRHDE	Missense_Mutation	p.S878F	C	C		8	Cancer Gene	12	73046194	73046194	94	0.170212765957447	NA	NA	NA			79			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRHDE&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,73046194,C,C&fts=all">p.S878F</a>
TRMT61A	Missense_Mutation	p.G251S	G	G		8	Cancer Gene	14	104001039	104001039	13	0.538461538461538	NA	NA	NA			1			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT61A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,14,104001039,G,G&fts=all">p.G251S</a>
USP42	Missense_Mutation	p.S729L	C	C	rs374947317	8	Cancer Gene	7	6190122	6190122	111	0.036036036036036	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USP42&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,7,6190122,C,C&fts=all">p.S729L</a>
VPS37A	Missense_Mutation	p.P156S	C	C		8	Cancer Gene	8	17132291	17132291	109	0.486238532110092	NA	NA	NA			10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS37A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,8,17132291,C,C&fts=all">p.P156S</a>
VPS8	Missense_Mutation	p.F1002Y	T	T		8	Cancer Gene	3	184658007	184658007	23	0.608695652173913	NA	NA	NA			54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VPS8&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,3,184658007,T,T&fts=all">p.F1002Y</a>
WDFY1	Missense_Mutation	p.L282V	A	A		8	Cancer Gene	2	224749454	224749454	117	0.239316239316239	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,224749454,A,A&fts=all">p.L282V</a>
WDFY3	Missense_Mutation	p.F927S	A	A		8	Cancer Gene	4	85722845	85722845	83	0.397590361445783	NA	NA	NA			134			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,85722845,A,A&fts=all">p.F927S</a>
WDFY3	Missense_Mutation	p.M926I	C	C		8	Cancer Gene	4	85722847	85722847	85	0.388235294117647	NA	NA	NA			134			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDFY3&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,4,85722847,C,C&fts=all">p.M926I</a>
WDR31	Missense_Mutation	p.P113L	G	G		8	Cancer Gene	9	116085422	116085422	34	0.823529411764706	NA	NA	NA			6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WDR31&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,9,116085422,G,G&fts=all">p.P113L</a>
WSCD1	Start_Codon_SNP	p.M1I	G	G		8	Cancer Gene	17	5983981	5983981	14	0.428571428571429	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+WSCD1&recr=Open">Click here</a>	
ZAP70	Missense_Mutation	p.R170H	G	G		8	Cancer Gene	2	98341661	98341661	42	0.214285714285714	NA	NA	NA			29	SH2 2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZAP70&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,98341661,G,G&fts=all">p.R170H</a>
ZIM2	Missense_Mutation	p.P312S	G	G		8	Cancer Gene	19	57286706	57286706	79	0.291139240506329	NA	NA	NA			44			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM2&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,57286706,G,G&fts=all">p.P312S</a>
ZNF484	Copy Number	Deleted	NA	NA	NA	8	Cancer Gene	9	95610835	95888922	NA	NA	25	-1.62905458742336	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF484&recr=Open">Click here</a>	
ZNF546	Missense_Mutation	p.H631Y	C	C		8	Cancer Gene	19	40521068	40521068	69	0.376811594202899	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF546&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,40521068,C,C&fts=all">p.H631Y</a>
ZNF675	Missense_Mutation	p.N110D	T	T		8	Cancer Gene	19	23837407	23837407	71	0.450704225352113	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF675&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,19,23837407,T,T&fts=all">p.N110D</a>
ANKRD19	Copy Number	Deleted	NA	NA	NA	9	VUS	9	95610835	95888922	NA	NA	25	-1.62905458742336	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD19&recr=Open">Click here</a>	
CBWD6	Copy Number	Deleted	NA	NA	NA	9	VUS	9	69205588	69238318	NA	NA	5	-1.11653558189768	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBWD6&recr=Open">Click here</a>	
CCL3L1	Copy Number	Deleted	NA	NA	NA	9	VUS	17	34590456	34641539	NA	NA	6	-1.07491204512002	TRUE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCL3L1&recr=Open">Click here</a>	
FOXD4L6	Copy Number	Deleted	NA	NA	NA	9	VUS	9	69205588	69238318	NA	NA	5	-1.11653558189768	FALSE		NA	NA	NA		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXD4L6&recr=Open">Click here</a>	
ANKS1B	Missense_Mutation	p.R496K	C	C		10	SNP	12	99837539	99837539	99	0.575757575757576	NA	NA	NA			70			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKS1B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,12,99837539,C,C&fts=all">p.R496K</a>
MROH2B	Missense_Mutation	p.S354L	G	G		10	SNP	5	41054915	41054915	87	0.413793103448276	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MROH2B&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,5,41054915,G,G&fts=all">p.S354L</a>
NXPE4	Missense_Mutation	p.P55R	G	G		10	SNP	11	114453676	114453676	101	0.198019801980198	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NXPE4&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,11,114453676,G,G&fts=all">p.P55R</a>
PALD1	Missense_Mutation	p.E211K	G	G		10	SNP	10	72291208	72291208	16	0.3125	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PALD1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,10,72291208,G,G&fts=all">p.E211K</a>
RP5-1043L13.1	lincRNA		G	G		10	SNP	20	58883608	58883608	21	0.380952380952381	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RP5-1043L13.1&recr=Open">Click here</a>	
SOGA1	Missense_Mutation	p.S529F	G	G		10	SNP	20	35444259	35444259	7	0.714285714285714	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SOGA1&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,20,35444259,G,G&fts=all">p.S529F</a>
TRABD2A	Missense_Mutation	p.L353R	A	A		10	SNP	2	85051206	85051206	12	0.333333333333333	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRABD2A&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,2,85051206,A,A&fts=all">p.L353R</a>
TSIX	lincRNA		C	C		10	SNP	X	73048905	73048905	56	0.678571428571429	NA	NA	NA						MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TSIX&recr=Open">Click here</a>	
ZNF683	Missense_Mutation	p.E143K	C	C		10	SNP	1	26691610	26691610	19	0.210526315789474	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF683&recr=Open">Click here</a>	<a href="http://mutationassessor.org/?cm=var&var=hg19,1,26691610,C,C&fts=all">p.E143K</a>
ABCA13	Silent	p.F4658F	C	C		11	Filtered Calls	7	48559813	48559813	47	0.276595744680851	NA	NA	NA			270			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ABCA13&recr=Open">Click here</a>	
ADAM28	Silent	p.G507G	G	G		11	Filtered Calls	8	24193108	24193108	15	0.733333333333333	NA	NA	NA			42	Cys-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM28&recr=Open">Click here</a>	
ADAM28	Silent	p.T559T	C	C		11	Filtered Calls	8	24199117	24199117	103	0.398058252427184	NA	NA	NA			42	Cys-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADAM28&recr=Open">Click here</a>	
ADARB1	Silent	p.A210A	T	T		11	Filtered Calls	21	46596246	46596246	28	0.214285714285714	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ADARB1&recr=Open">Click here</a>	
AJUBA	Intron		G	G		11	Filtered Calls	14	23442783	23442783	22	0.227272727272727	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AJUBA&recr=Open">Click here</a>	
AKAP4	Silent	p.L765L	G	G		11	Filtered Calls	X	49957042	49957042	10	0.7	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AKAP4&recr=Open">Click here</a>	
ANK1	Intron		C	C		11	Filtered Calls	8	41573376	41573376	41	0.560975609756098	NA	NA	NA		p.?(2)	122			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANK1&recr=Open">Click here</a>	
ANKRD24	Intron		A	A	rs372984726	11	Filtered Calls	19	4224418	4224418	16	0.4375	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ANKRD24&recr=Open">Click here</a>	
APOB	Silent	p.G1701G	C	C		11	Filtered Calls	2	21234637	21234637	80	0.2375	NA	NA	NA			305			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+APOB&recr=Open">Click here</a>	
AQP7	Silent	p.Q26Q	C	C		11	Filtered Calls	9	33395142	33395142	28	0.714285714285714	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+AQP7&recr=Open">Click here</a>	
ARHGAP22	Silent	p.S420S	G	G	rs370518102	11	Filtered Calls	10	49658930	49658930	7	0.571428571428571	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARHGAP22&recr=Open">Click here</a>	
ARMC1	Intron		G	G		11	Filtered Calls	8	66516829	66516829	36	0.388888888888889	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ARMC1&recr=Open">Click here</a>	
ASAP3	Silent	p.I429I	G	G		11	Filtered Calls	1	23763678	23763678	10	0.6	NA	NA	NA			24	Arf-GAP. {ECO:0000255|PROSITE- ProRule:PRU00288}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ASAP3&recr=Open">Click here</a>	
ATAD2	5'UTR		G	G		11	Filtered Calls	8	124361659	124361659	155	0.412903225806452	NA	NA	NA			48			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATAD2&recr=Open">Click here</a>	
ATF7IP2	Intron		A	A		11	Filtered Calls	16	10575660	10575660	27	0.333333333333333	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATF7IP2&recr=Open">Click here</a>	
ATP12A	Silent	p.T775T	A	A		11	Filtered Calls	13	25281316	25281316	37	0.513513513513513	NA	NA	NA			74			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP12A&recr=Open">Click here</a>	
ATP13A4	Silent	p.E698E	C	C		11	Filtered Calls	3	193166053	193166053	85	0.576470588235294	NA	NA	NA			71			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATP13A4&recr=Open">Click here</a>	
ATXN2L	Silent	p.S684S	C	C		11	Filtered Calls	16	28845394	28845394	53	0.339622641509434	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ATXN2L&recr=Open">Click here</a>	
BATF3	Silent	p.L77L	C	C		11	Filtered Calls	1	212860286	212860286	117	0.692307692307692	NA	NA	NA			6	Leucine-zipper. {ECO:0000255|PROSITE- ProRule:PRU00978}.|bZIP. {ECO:0000255|PROSITE- ProRule:PRU00978}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BATF3&recr=Open">Click here</a>	
BLNK	Silent	p.K412K	C	C		11	Filtered Calls	10	97956679	97956679	68	0.397058823529412	NA	NA	NA			14	SH2. {ECO:0000255|PROSITE- ProRule:PRU00191}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BLNK&recr=Open">Click here</a>	
BOC	Silent	p.S1098S	C	C		11	Filtered Calls	3	113005658	113005658	72	0.625	NA	NA	NA			68			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BOC&recr=Open">Click here</a>	
BPI	Silent	p.G35G	C	C		11	Filtered Calls	20	36932718	36932718	30	0.166666666666667	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+BPI&recr=Open">Click here</a>	
C10orf107	Intron		C	C		11	Filtered Calls	10	63445796	63445796	57	0.228070175438596	NA	NA	NA			8			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf107&recr=Open">Click here</a>	
C10orf128	Silent	p.F34F	G	G		11	Filtered Calls	10	50375050	50375050	26	0.153846153846154	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C10orf128&recr=Open">Click here</a>	
C14orf164	IGR		G	G	rs374986307	11	Filtered Calls	14	23744926	23744926	6	0.5	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C14orf164&recr=Open">Click here</a>	
C15orf39	Silent	p.I462I	C	C	rs572231506	11	Filtered Calls	15	75499775	75499775	27	0.296296296296296	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C15orf39&recr=Open">Click here</a>	
C1QTNF1	5'UTR		G	G		11	Filtered Calls	17	77040205	77040205	12	0.416666666666667	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C1QTNF1&recr=Open">Click here</a>	
C22orf43	Intron		C	C		11	Filtered Calls	22	23955470	23955470	115	0.31304347826087	NA	NA	NA			11			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C22orf43&recr=Open">Click here</a>	
C6orf118	Silent	p.L24L	G	G		11	Filtered Calls	6	165715741	165715741	63	0.650793650793651	NA	NA	NA		p.L24L(1)	40			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+C6orf118&recr=Open">Click here</a>	
CAPN13	Silent	p.F408F	G	G		11	Filtered Calls	2	30973981	30973981	33	0.303030303030303	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CAPN13&recr=Open">Click here</a>	
CBLB	Silent	p.I575I	G	G	rs202207806	11	Filtered Calls	3	105421172	105421172	43	0.534883720930233	NA	NA	NA			49	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CBLB&recr=Open">Click here</a>	
CCDC141	5'UTR		C	C		11	Filtered Calls	2	179702169	179702169	49	0.551020408163265	NA	NA	NA			78			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	
CCDC141	5'UTR		C	C		11	Filtered Calls	2	179702471	179702471	82	0.378048780487805	NA	NA	NA			78			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC141&recr=Open">Click here</a>	
CCDC83	Silent	p.E66E	A	A		11	Filtered Calls	11	85593573	85593573	99	0.616161616161616	NA	NA	NA			29			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CCDC83&recr=Open">Click here</a>	
CD163	5'Flank		G	G		11	Filtered Calls	12	7635291	7635291	115	0.504347826086956	NA	NA	NA			76			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD163&recr=Open">Click here</a>	
CD33	Silent	p.R98R	G	G		11	Filtered Calls	19	51728730	51728730	43	0.395348837209302	NA	NA	NA			24	Ig-like V-type.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CD33&recr=Open">Click here</a>	
CDH18	3'UTR		G	G		11	Filtered Calls	5	19483441	19483441	48	0.375	NA	NA	NA			138			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH18&recr=Open">Click here</a>	
CDH20	Silent	p.V663V	C	C		11	Filtered Calls	18	59221511	59221511	198	0.272727272727273	NA	NA	NA			61			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH20&recr=Open">Click here</a>	
CDH6	Silent	p.R678R	G	G		11	Filtered Calls	5	31323076	31323076	47	0.361702127659574	NA	NA	NA			77			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDH6&recr=Open">Click here</a>	
CDKAL1	Intron		A	A		11	Filtered Calls	6	21201338	21201338	131	0.229007633587786	NA	NA	NA			29			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CDKAL1&recr=Open">Click here</a>	
CELSR2	Silent	p.P1268P	C	C	rs201183175	11	Filtered Calls	1	109801547	109801547	26	0.615384615384615	NA	NA	NA			82	EGF-like 1; calcium-binding. {ECO:0000255|PROSITE-ProRule:PRU00076}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CELSR2&recr=Open">Click here</a>	
CHFR	Silent	p.E408E	C	C		11	Filtered Calls	12	133428232	133428232	75	0.266666666666667	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHFR&recr=Open">Click here</a>	
CHIT1	Intron		G	G		11	Filtered Calls	1	203188984	203188984	14	0.642857142857143	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHIT1&recr=Open">Click here</a>	
CHMP1B	Silent	p.F13F	C	C		11	Filtered Calls	18	11851549	11851549	18	0.666666666666667	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CHMP1B&recr=Open">Click here</a>	
CLEC10A	Intron		C	C		11	Filtered Calls	17	6979426	6979426	27	0.666666666666667	NA	NA	NA			10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC10A&recr=Open">Click here</a>	
CLEC6A	Silent	p.I193I	C	C		11	Filtered Calls	12	8630009	8630009	104	0.394230769230769	NA	NA	NA			10	C-type lectin. {ECO:0000255|PROSITE- ProRule:PRU00040}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CLEC6A&recr=Open">Click here</a>	
CNKSR1	Silent	p.P342P	C	C		11	Filtered Calls	1	26510917	26510917	16	0.3125	NA	NA	NA			28	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CNKSR1&recr=Open">Click here</a>	
COL4A2	Intron		C	C		11	Filtered Calls	13	111092128	111092128	107	0.514018691588785	NA	NA	NA			80			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL4A2&recr=Open">Click here</a>	
COL7A1	Intron		C	C		11	Filtered Calls	3	48617459	48617459	73	0.301369863013699	NA	NA	NA			137			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COL7A1&recr=Open">Click here</a>	
COPB1	Silent	p.P772P	C	C	rs567593749	11	Filtered Calls	11	14486551	14486551	119	0.0420168067226891	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+COPB1&recr=Open">Click here</a>	
CRELD1	5'UTR		A	A		11	Filtered Calls	3	9976120	9976120	84	0.285714285714286	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRELD1&recr=Open">Click here</a>	
CRLF1	Silent	p.P239P	G	G		11	Filtered Calls	19	18707840	18707840	16	0.625	NA	NA	NA			9	Fibronectin type-III 2. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CRLF1&recr=Open">Click here</a>	
CSMD1	Silent	p.V651V	G	G	rs191152555	11	Filtered Calls	8	3265542	3265542	44	0.113636363636364	NA	NA	NA			25	CUB 4. {ECO:0000255|PROSITE- ProRule:PRU00059}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CSMD1&recr=Open">Click here</a>	
CTC-326K19.6	Intron		C	C		11	Filtered Calls	19	50453441	50453441	9	0.333333333333333	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC-326K19.6&recr=Open">Click here</a>	
CTC-490G23.4	RNA		G	G		11	Filtered Calls	19	43864458	43864458	22	0.272727272727273	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC-490G23.4&recr=Open">Click here</a>	
CTC-490G23.4	RNA		G	G		11	Filtered Calls	19	43864459	43864459	22	0.272727272727273	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTC-490G23.4&recr=Open">Click here</a>	
CTD-3222D19.2	Intron		C	C		11	Filtered Calls	19	16641580	16641580	39	0.128205128205128	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTD-3222D19.2&recr=Open">Click here</a>	
CTNNBL1	5'UTR		C	C		11	Filtered Calls	20	36374882	36374882	134	0.395522388059701	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CTNNBL1&recr=Open">Click here</a>	
CUZD1	Silent	p.S219S	G	G		11	Filtered Calls	10	124596507	124596507	43	0.395348837209302	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CUZD1&recr=Open">Click here</a>	
CXorf58	Silent	p.N232N	C	C		11	Filtered Calls	X	23953453	23953453	61	0.655737704918033	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+CXorf58&recr=Open">Click here</a>	
DACH2	Silent	p.L466L	C	C		11	Filtered Calls	X	86068139	86068139	14	0.714285714285714	NA	NA	NA			71	DACHbox-C.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DACH2&recr=Open">Click here</a>	
DDX18	Silent	p.K153K	G	G		11	Filtered Calls	2	118577313	118577313	54	0.37037037037037	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DDX18&recr=Open">Click here</a>	
DGKI	Intron		A	A		11	Filtered Calls	7	137151640	137151640	131	0.290076335877863	NA	NA	NA			84			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKI&recr=Open">Click here</a>	
DGKK	RNA		C	C		11	Filtered Calls	X	50133358	50133358	56	0.660714285714286	NA	NA	NA			45			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DGKK&recr=Open">Click here</a>	
DNA2	Intron		T	T		11	Filtered Calls	10	70191930	70191930	49	0.163265306122449	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNA2&recr=Open">Click here</a>	
DNAH10	Silent	p.L1338L	G	G		11	Filtered Calls	12	124311422	124311422	46	0.41304347826087	NA	NA	NA			52	Stem. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH10&recr=Open">Click here</a>	
DNAH5	Silent	p.E1493E	C	C		11	Filtered Calls	5	13864623	13864623	54	0.277777777777778	NA	NA	NA		p.E1493E(1)	378	Stem. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH5&recr=Open">Click here</a>	
DNAH9	Silent	p.G1884G	C	C		11	Filtered Calls	17	11622750	11622750	26	0.461538461538462	NA	NA	NA			290	AAA 1. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DNAH9&recr=Open">Click here</a>	
DOCK10	Intron		A	A		11	Filtered Calls	2	225721573	225721573	53	0.433962264150943	NA	NA	NA			87			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DOCK10&recr=Open">Click here</a>	
DSC1	Silent	p.S93S	G	G		11	Filtered Calls	18	28737406	28737406	96	0.270833333333333	NA	NA	NA			53			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DSC1&recr=Open">Click here</a>	
DYRK2	Intron		C	C	rs535478382	11	Filtered Calls	12	68043574	68043574	22	0.363636363636364	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+DYRK2&recr=Open">Click here</a>	
EIF5	Intron		A	A		11	Filtered Calls	14	103802362	103802362	154	0.201298701298701	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EIF5&recr=Open">Click here</a>	
EMR1	Silent	p.Y44Y	T	T		11	Filtered Calls	19	6896446	6896446	81	0.296296296296296	NA	NA	NA			62	EGF-like 1. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EMR1&recr=Open">Click here</a>	
EPS15L1	Silent	p.P101P	A	A		11	Filtered Calls	19	16548587	16548587	76	0.0526315789473684	NA	NA	NA			30	EH 1. {ECO:0000255|PROSITE- ProRule:PRU00077}.|Interaction with DAB2. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+EPS15L1&recr=Open">Click here</a>	
FABP6	Silent	p.I37I	C	C		11	Filtered Calls	5	159659148	159659148	31	0.193548387096774	NA	NA	NA			5			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FABP6&recr=Open">Click here</a>	
FAM78B	3'UTR		C	C		11	Filtered Calls	1	166039472	166039472	72	0.680555555555556	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAM78B&recr=Open">Click here</a>	
FAT3	Silent	p.Y4072Y	C	C		11	Filtered Calls	11	92616288	92616288	88	0.579545454545455	NA	NA	NA			85	EGF-like 3. {ECO:0000255|PROSITE- ProRule:PRU00076}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FAT3&recr=Open">Click here</a>	
FGD5	Silent	p.G1125G	G	G		11	Filtered Calls	3	14952406	14952406	22	0.409090909090909	NA	NA	NA			54	PH 1. {ECO:0000255|PROSITE- ProRule:PRU00145}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FGD5&recr=Open">Click here</a>	
FILIP1L	Silent	p.E174E	C	C		11	Filtered Calls	3	99643157	99643157	132	0.583333333333333	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FILIP1L&recr=Open">Click here</a>	
FOXN3	Silent	p.L41L	G	G	rs145009047	11	Filtered Calls	14	89878698	89878698	154	0.168831168831169	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FOXN3&recr=Open">Click here</a>	
FRMPD2	Silent	p.A275A	C	C	rs149962060	11	Filtered Calls	10	49446130	49446130	37	0.0810810810810811	NA	NA	NA		p.A275A(1)	66			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FRMPD2&recr=Open">Click here</a>	
FTMT	Silent	p.P61P	C	C		11	Filtered Calls	5	121187841	121187841	20	0.15	NA	NA	NA			33			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FTMT&recr=Open">Click here</a>	
FUT7	Silent	p.S120S	G	G		11	Filtered Calls	9	139925831	139925831	9	0.555555555555556	NA	NA	NA			8			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FUT7&recr=Open">Click here</a>	
FYCO1	Silent	p.E611E	C	C		11	Filtered Calls	3	46008993	46008993	95	0.0421052631578947	NA	NA	NA			54			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+FYCO1&recr=Open">Click here</a>	
GABRE	Intron		G	G		11	Filtered Calls	X	151127123	151127123	44	0.772727272727273	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GABRE&recr=Open">Click here</a>	
GLCCI1	Silent	p.F453F	C	C		11	Filtered Calls	7	8125883	8125883	213	0.455399061032864	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLCCI1&recr=Open">Click here</a>	
GLP1R	Silent	p.R121R	G	G		11	Filtered Calls	6	39033566	39033566	16	0.3125	NA	NA	NA			31			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GLP1R&recr=Open">Click here</a>	
GNAL	Intron		C	C		11	Filtered Calls	18	11880979	11880979	29	0.551724137931034	NA	NA	NA			12			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GNAL&recr=Open">Click here</a>	
GOLGA2	5'Flank		G	G		11	Filtered Calls	9	131038413	131038413	125	0.656	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GOLGA2&recr=Open">Click here</a>	
GPM6A	5'UTR		G	G		11	Filtered Calls	4	176733380	176733380	155	0.032258064516129	NA	NA	NA			33			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPM6A&recr=Open">Click here</a>	
GPX6	Silent	p.L12L	G	G		11	Filtered Calls	6	28483487	28483487	71	0.507042253521127	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GPX6&recr=Open">Click here</a>	
GRM7	Intron		C	C		11	Filtered Calls	3	7728037	7728037	98	0.275510204081633	NA	NA	NA			76			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+GRM7&recr=Open">Click here</a>	
HAMP	Silent	p.F63F	C	C		11	Filtered Calls	19	35775879	35775879	90	0.411111111111111	NA	NA	NA			4			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HAMP&recr=Open">Click here</a>	
HCN4	Silent	p.V686V	C	C		11	Filtered Calls	15	73616515	73616515	37	0.405405405405405	NA	NA	NA			55			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HCN4&recr=Open">Click here</a>	
HDAC9	Silent	p.S267S	G	G		11	Filtered Calls	7	18687413	18687413	25	0.28	NA	NA	NA			82	Interaction with MAPK10. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HDAC9&recr=Open">Click here</a>	
HFE	Silent	p.K249K	G	G		11	Filtered Calls	6	26093043	26093043	53	0.320754716981132	NA	NA	NA			19	Alpha-3.|Ig-like C1-type.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HFE&recr=Open">Click here</a>	
HGFAC	Silent	p.P334P	C	C		11	Filtered Calls	4	3446706	3446706	19	0.421052631578947	NA	NA	NA			22	Kringle. {ECO:0000255|PROSITE- ProRule:PRU00121}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HGFAC&recr=Open">Click here</a>	
HIVEP3	Silent	p.E2173E	C	C		11	Filtered Calls	1	41976824	41976824	68	0.588235294117647	NA	NA	NA			85			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HIVEP3&recr=Open">Click here</a>	
HKDC1	Silent	p.L270L	G	G		11	Filtered Calls	10	71003056	71003056	69	0.173913043478261	NA	NA	NA			34	Hexokinase type-2 1.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HKDC1&recr=Open">Click here</a>	
HLA-G	Silent	p.F60F	C	C		11	Filtered Calls	6	29795930	29795930	37	0.567567567567568	NA	NA	NA			21	Alpha-1.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HLA-G&recr=Open">Click here</a>	
HMGCR	Silent	p.T183T	C	C		11	Filtered Calls	5	74643127	74643127	127	0.338582677165354	NA	NA	NA			20	SSD. {ECO:0000255|PROSITE- ProRule:PRU00199}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HMGCR&recr=Open">Click here</a>	
HRH1	Silent	p.R262R	G	G		11	Filtered Calls	3	11301509	11301509	40	0.425	NA	NA	NA			25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HRH1&recr=Open">Click here</a>	
HS3ST4	Silent	p.K392K	G	G		11	Filtered Calls	16	26147374	26147374	15	0.2	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HS3ST4&recr=Open">Click here</a>	
HSD17B4	Silent	p.E249E	G	G		11	Filtered Calls	5	118829574	118829574	86	0.348837209302326	NA	NA	NA			25	(3R)-hydroxyacyl-CoA dehydrogenase.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HSD17B4&recr=Open">Click here</a>	
HTR2C	Intron		C	C		11	Filtered Calls	X	114058057	114058057	10	0.5	NA	NA	NA			50			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+HTR2C&recr=Open">Click here</a>	
IFNA8	Silent	p.L119L	G	G		11	Filtered Calls	9	21409532	21409532	72	0.666666666666667	NA	NA	NA		p.L119L(1)	9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IFNA8&recr=Open">Click here</a>	
IGHV3-20	RNA		C	C		11	Filtered Calls	14	106667584	106667584	129	0.10077519379845	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IGHV3-20&recr=Open">Click here</a>	
IL36B	Intron		G	G		11	Filtered Calls	2	113780365	113780365	32	0.40625	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL36B&recr=Open">Click here</a>	
IL36G	Silent	p.F117F	C	C		11	Filtered Calls	2	113742467	113742467	76	0.355263157894737	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL36G&recr=Open">Click here</a>	
IL8	Intron		C	C		11	Filtered Calls	4	74607250	74607250	97	0.0412371134020619	NA	NA	NA		p.?(1)	6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IL8&recr=Open">Click here</a>	
INHBA	Silent	p.I333I	G	G		11	Filtered Calls	7	41729530	41729530	92	0.423913043478261	NA	NA	NA		p.I333I(1)	55			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INHBA&recr=Open">Click here</a>	
INTS10	Silent	p.F623F	C	C	rs549241946	11	Filtered Calls	8	19701736	19701736	70	0.228571428571429	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+INTS10&recr=Open">Click here</a>	
IQCF3	Silent	p.R74R	G	G		11	Filtered Calls	3	51864574	51864574	34	0.205882352941176	NA	NA	NA			6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+IQCF3&recr=Open">Click here</a>	
ITGB4	Silent	p.S1387S	C	C		11	Filtered Calls	17	73750709	73750709	40	0.3	NA	NA	NA			43			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITGB4&recr=Open">Click here</a>	
ITIH2	Silent	p.R186R	G	G		11	Filtered Calls	10	7759712	7759712	55	0.181818181818182	NA	NA	NA			64			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ITIH2&recr=Open">Click here</a>	
KALRN	Intron		C	C	rs372675411	11	Filtered Calls	3	124196084	124196084	71	0.605633802816901	NA	NA	NA			83			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KALRN&recr=Open">Click here</a>	
KAT6B	Silent	p.S1594S	G	G		11	Filtered Calls	10	76789364	76789364	39	0.205128205128205	NA	NA	NA			NA	Interaction with RUNX1 and RUNX2.|Ser-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KAT6B&recr=Open">Click here</a>	
KIAA1009	Intron		G	G		11	Filtered Calls	6	84856509	84856509	19	0.315789473684211	NA	NA	NA			43			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1009&recr=Open">Click here</a>	
KIAA1217	Intron		C	C		11	Filtered Calls	10	24832826	24832826	46	0.391304347826087	NA	NA	NA			70			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1217&recr=Open">Click here</a>	
KIAA1324L	Silent	p.G695G	C	C		11	Filtered Calls	7	86526921	86526921	92	0.369565217391304	NA	NA	NA			44			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1324L&recr=Open">Click here</a>	
KIAA1598	5'UTR		G	G	rs181863139	11	Filtered Calls	10	118661351	118661351	54	0.259259259259259	NA	NA	NA			10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIAA1598&recr=Open">Click here</a>	
KIRREL2	Intron		C	C		11	Filtered Calls	19	36350372	36350372	32	0.28125	NA	NA	NA			48			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KIRREL2&recr=Open">Click here</a>	
KLRC4	Intron		C	C		11	Filtered Calls	12	10560918	10560918	77	0.207792207792208	NA	NA	NA			5			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+KLRC4&recr=Open">Click here</a>	
L2HGDH	Intron		G	G		11	Filtered Calls	14	50713830	50713830	85	0.435294117647059	NA	NA	NA			10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+L2HGDH&recr=Open">Click here</a>	
LAMB4	Intron		G	G		11	Filtered Calls	7	107746487	107746487	67	0.373134328358209	NA	NA	NA			97			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LAMB4&recr=Open">Click here</a>	
LBP	5'UTR		G	G		11	Filtered Calls	20	36974910	36974910	42	0.166666666666667	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LBP&recr=Open">Click here</a>	
LBP	Silent	p.I228I	T	T		11	Filtered Calls	20	36992660	36992660	57	0.508771929824561	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LBP&recr=Open">Click here</a>	
LHFPL5	Silent	p.I175I	C	C	rs557741915	11	Filtered Calls	6	35782435	35782435	30	0.433333333333333	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LHFPL5&recr=Open">Click here</a>	
LMLN	Silent	p.T220T	C	C	rs566428236	11	Filtered Calls	3	197707307	197707307	87	0.609195402298851	NA	NA	NA		p.T220T(1)	25			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LMLN&recr=Open">Click here</a>	
LRP1B	Silent	p.V2271V	C	C		11	Filtered Calls	2	141359195	141359195	23	0.478260869565217	NA	NA	NA			606			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRP1B&recr=Open">Click here</a>	
LRRK1	Silent	p.L344L	C	C		11	Filtered Calls	15	101550697	101550697	123	0.341463414634146	NA	NA	NA			72			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LRRK1&recr=Open">Click here</a>	
LY6G6C	5'Flank		C	C		11	Filtered Calls	6	31691585	31691585	110	0.454545454545455	NA	NA	NA			4			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+LY6G6C&recr=Open">Click here</a>	
MAGEA3	Silent	p.I177I	G	G		11	Filtered Calls	X	151935636	151935636	65	0.784615384615385	NA	NA	NA			15	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAGEA3&recr=Open">Click here</a>	
MAK	Silent	p.G11G	C	C		11	Filtered Calls	6	10830849	10830849	104	0.432692307692308	NA	NA	NA			22	Protein kinase. {ECO:0000255|PROSITE- ProRule:PRU00159}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MAK&recr=Open">Click here</a>	
MCTP1	Intron		G	G		11	Filtered Calls	5	94253685	94253685	78	0.282051282051282	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MCTP1&recr=Open">Click here</a>	
MICU1	Silent	p.S182S	G	G		11	Filtered Calls	10	74268019	74268019	19	0.578947368421053	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MICU1&recr=Open">Click here</a>	
MMP13	Silent	p.L52L	G	G		11	Filtered Calls	11	102826187	102826187	125	0.664	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MMP13&recr=Open">Click here</a>	
MPST	5'Flank		G	G		11	Filtered Calls	22	37414295	37414295	45	0.333333333333333	NA	NA	NA			7			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MPST&recr=Open">Click here</a>	
MRPL46	5'Flank		G	G	rs367612805	11	Filtered Calls	15	89008965	89008965	110	0.427272727272727	NA	NA	NA			5			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MRPL46&recr=Open">Click here</a>	
MTO1	Silent	p.A244A	C	C		11	Filtered Calls	6	74183284	74183284	121	0.0330578512396694	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTO1&recr=Open">Click here</a>	
MTOR	Silent	p.L2123L	C	C		11	Filtered Calls	1	11186836	11186836	122	0.483606557377049	NA	NA	NA			149	Sufficient for interaction with the FKBP1A/rapamycin complex. {ECO:0000250}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MTOR&recr=Open">Click here</a>	
MUC16	Silent	p.R10170R	C	C		11	Filtered Calls	19	9056936	9056936	26	0.423076923076923	NA	NA	NA			590	Ser-rich.|Thr-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC16&recr=Open">Click here</a>	
MUC4	Intron		C	C		11	Filtered Calls	3	195515915	195515915	26	0.653846153846154	NA	NA	NA			51			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MUC4&recr=Open">Click here</a>	
MYH14	Silent	p.L352L	C	C		11	Filtered Calls	19	50735269	50735269	34	0.323529411764706	NA	NA	NA			46	Myosin motor.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	
MYH14	Silent	p.S1170S	C	C		11	Filtered Calls	19	50779290	50779290	21	0.428571428571429	NA	NA	NA			46			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH14&recr=Open">Click here</a>	
MYH2	Intron		G	G		11	Filtered Calls	17	10438643	10438643	44	0.613636363636364	NA	NA	NA			176			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYH2&recr=Open">Click here</a>	
MYO5B	Intron		G	G		11	Filtered Calls	18	47438551	47438551	33	0.515151515151515	NA	NA	NA			87			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+MYO5B&recr=Open">Click here</a>	
NEB	Silent	p.K662K	C	C		11	Filtered Calls	2	152548787	152548787	65	0.430769230769231	NA	NA	NA			301			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NEB&recr=Open">Click here</a>	
NLGN4Y	3'UTR		C	C		11	Filtered Calls	Y	16734010	16734010	9	0.444444444444444	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLGN4Y&recr=Open">Click here</a>	
NLRC3	RNA		C	C		11	Filtered Calls	16	3614963	3614963	13	0.538461538461538	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRC3&recr=Open">Click here</a>	
NLRP8	Silent	p.H817H	T	T		11	Filtered Calls	19	56481979	56481979	130	0.384615384615385	NA	NA	NA			35			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NLRP8&recr=Open">Click here</a>	
NPNT	Silent	p.G40G	G	G		11	Filtered Calls	4	106819106	106819106	46	0.217391304347826	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NPNT&recr=Open">Click here</a>	
NSFL1C	Silent	p.T57T	G	G		11	Filtered Calls	20	1445006	1445006	147	0.36734693877551	NA	NA	NA			16			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NSFL1C&recr=Open">Click here</a>	
NT5C1A	Silent	p.L84L	C	C		11	Filtered Calls	1	40131792	40131792	68	0.132352941176471	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+NT5C1A&recr=Open">Click here</a>	
OGDHL	Silent	p.T420T	C	C		11	Filtered Calls	10	50954832	50954832	27	0.407407407407407	NA	NA	NA			61			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OGDHL&recr=Open">Click here</a>	
OR13H1	Silent	p.R301R	G	G		11	Filtered Calls	X	130678950	130678950	61	0.770491803278688	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR13H1&recr=Open">Click here</a>	
OR2A5	Silent	p.A188A	C	C		11	Filtered Calls	7	143748058	143748058	140	0.207142857142857	NA	NA	NA			38			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR2A5&recr=Open">Click here</a>	
OR52J3	Silent	p.L22L	G	G		11	Filtered Calls	11	5067821	5067821	144	0.631944444444444	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR52J3&recr=Open">Click here</a>	
OR56A3	Silent	p.F39F	C	C	rs267603043	11	Filtered Calls	11	5968693	5968693	47	0.723404255319149	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR56A3&recr=Open">Click here</a>	
OR6A2	Silent	p.A242A	G	G		11	Filtered Calls	11	6816214	6816214	52	0.692307692307692	NA	NA	NA			29			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+OR6A2&recr=Open">Click here</a>	
PABPC4	Silent	p.K188K	C	C		11	Filtered Calls	1	40035614	40035614	140	0.1	NA	NA	NA			21			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PABPC4&recr=Open">Click here</a>	
PANK2	Intron		A	A		11	Filtered Calls	20	3891489	3891489	109	0.385321100917431	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PANK2&recr=Open">Click here</a>	
PCDHA2	Intron		C	C		11	Filtered Calls	5	140182649	140182649	67	0.343283582089552	NA	NA	NA			71			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA2&recr=Open">Click here</a>	
PCDHA9	Intron		C	C		11	Filtered Calls	5	140248681	140248681	94	0.297872340425532	NA	NA	NA			59			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHA9&recr=Open">Click here</a>	
PCDHB11	Silent	p.G82G	G	G	rs116026964	11	Filtered Calls	5	140579593	140579593	74	0.364864864864865	NA	NA	NA			63	Cadherin 1. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB11&recr=Open">Click here</a>	
PCDHB5	Silent	p.A474A	C	C		11	Filtered Calls	5	140516438	140516438	102	0.215686274509804	NA	NA	NA			81	Cadherin 5. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHB5&recr=Open">Click here</a>	
PCDHGA5	Silent	p.L440L	G	G		11	Filtered Calls	5	140745217	140745217	117	0.367521367521368	NA	NA	NA			18	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PCDHGA5&recr=Open">Click here</a>	
PDE6H	Silent	p.G81G	G	G		11	Filtered Calls	12	15134401	15134401	74	0.256756756756757	NA	NA	NA		p.G81G(2)	10			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PDE6H&recr=Open">Click here</a>	
PID1	Silent	p.T68T	G	G		11	Filtered Calls	2	229890798	229890798	44	0.181818181818182	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PID1&recr=Open">Click here</a>	
PIWIL2	Intron		C	C		11	Filtered Calls	8	22210735	22210735	90	0.0444444444444444	NA	NA	NA			46			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PIWIL2&recr=Open">Click here</a>	
PLEKHA4	Silent	p.G176G	G	G		11	Filtered Calls	19	49362890	49362890	46	0.521739130434783	NA	NA	NA			30	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLEKHA4&recr=Open">Click here</a>	
PLXDC2	Silent	p.F182F	C	C		11	Filtered Calls	10	20432228	20432228	89	0.202247191011236	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PLXDC2&recr=Open">Click here</a>	
POLR3B	Intron		C	C		11	Filtered Calls	12	106827485	106827485	74	0.256756756756757	NA	NA	NA			57			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+POLR3B&recr=Open">Click here</a>	
PREX2	Intron		G	G	rs374665840	11	Filtered Calls	8	68989710	68989710	71	0.309859154929577	NA	NA	NA			178			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PREX2&recr=Open">Click here</a>	
PRKCB	Intron		C	C		11	Filtered Calls	16	24226094	24226094	81	0.172839506172839	NA	NA	NA			9			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRKCB&recr=Open">Click here</a>	
PRLR	Intron		A	A		11	Filtered Calls	5	35086301	35086301	75	0.32	NA	NA	NA			48			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PRLR&recr=Open">Click here</a>	
PSAT1	Intron		C	C		11	Filtered Calls	9	80932727	80932727	66	0.46969696969697	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PSAT1&recr=Open">Click here</a>	
PTCHD3	Silent	p.A321A	G	G		11	Filtered Calls	10	27702217	27702217	33	0.303030303030303	NA	NA	NA			55			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTCHD3&recr=Open">Click here</a>	
PTGIS	Intron		C	C		11	Filtered Calls	20	48127562	48127562	39	0.333333333333333	NA	NA	NA			27			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+PTGIS&recr=Open">Click here</a>	
RBP3	Intron		G	G		11	Filtered Calls	10	48385837	48385837	28	0.392857142857143	NA	NA	NA			59			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RBP3&recr=Open">Click here</a>	
RCC2	Silent	p.P246P	G	G	rs374421061	11	Filtered Calls	1	17748705	17748705	109	0.165137614678899	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RCC2&recr=Open">Click here</a>	
RGS3	Silent	p.Q732Q	G	G		11	Filtered Calls	9	116345888	116345888	46	0.0652173913043478	NA	NA	NA			48	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RGS3&recr=Open">Click here</a>	
RNF216	Silent	p.A840A	G	G		11	Filtered Calls	7	5662743	5662743	96	0.270833333333333	NA	NA	NA			33	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RNF216&recr=Open">Click here</a>	
RRP12	Intron		G	G		11	Filtered Calls	10	99129171	99129171	12	0.25	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RRP12&recr=Open">Click here</a>	
RUNDC3B	Silent	p.S285S	C	C		11	Filtered Calls	7	87407170	87407170	120	0.375	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RUNDC3B&recr=Open">Click here</a>	
RYR1	Intron		C	C		11	Filtered Calls	19	38959933	38959933	15	0.466666666666667	NA	NA	NA			285			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
RYR1	Intron		G	G	rs374325589	11	Filtered Calls	19	39018432	39018432	50	0.3	NA	NA	NA			285			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+RYR1&recr=Open">Click here</a>	
SAE1	Silent	p.G170G	A	A		11	Filtered Calls	19	47656280	47656280	170	0.341176470588235	NA	NA	NA			13			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SAE1&recr=Open">Click here</a>	
SCN11A	Silent	p.F1607F	G	G		11	Filtered Calls	3	38888740	38888740	116	0.301724137931034	NA	NA	NA			119			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SCN11A&recr=Open">Click here</a>	
SDK2	Silent	p.I546I	G	G		11	Filtered Calls	17	71420177	71420177	22	0.181818181818182	NA	NA	NA			86	Ig-like C2-type 6.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SDK2&recr=Open">Click here</a>	
SERPINB11	RNA		G	G		11	Filtered Calls	18	61387274	61387274	173	0.485549132947977	NA	NA	NA			6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB11&recr=Open">Click here</a>	
SERPINB11	RNA		C	C		11	Filtered Calls	18	61387323	61387323	123	0.357723577235772	NA	NA	NA			6			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINB11&recr=Open">Click here</a>	
SERPINI2	Intron		C	C		11	Filtered Calls	3	167170716	167170716	76	0.578947368421053	NA	NA	NA			41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SERPINI2&recr=Open">Click here</a>	
SLC12A1	Silent	p.L963L	G	G		11	Filtered Calls	15	48583990	48583990	14	0.428571428571429	NA	NA	NA			59			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC12A1&recr=Open">Click here</a>	
SLC25A10	Silent	p.I121I	C	C		11	Filtered Calls	17	79673953	79673953	39	0.41025641025641	NA	NA	NA			14			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC25A10&recr=Open">Click here</a>	
SLC7A8	5'UTR		C	C		11	Filtered Calls	14	23652124	23652124	106	0.358490566037736	NA	NA	NA			24			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SLC7A8&recr=Open">Click here</a>	
SMAD4	Intron		A	A		11	Filtered Calls	18	48584708	48584708	89	0.0561797752808989	NA	NA	NA		p.0?(36)|p.?(2)	454			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SMAD4&recr=Open">Click here</a>	
SND1	Silent	p.F251F	C	C		11	Filtered Calls	7	127343290	127343290	155	0.309677419354839	NA	NA	NA			41	TNase-like 2. {ECO:0000255|PROSITE- ProRule:PRU00272}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SND1&recr=Open">Click here</a>	
SND1	Intron		C	C		11	Filtered Calls	7	127637871	127637871	160	0.28125	NA	NA	NA		p.S42L(1)	41			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SND1&recr=Open">Click here</a>	
SNHG14	RNA		C	C		11	Filtered Calls	15	25438522	25438522	93	0.172043010752688	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNHG14&recr=Open">Click here</a>	
SNORD113-8	RNA		C	C		11	Filtered Calls	14	101409840	101409840	127	0.094488188976378	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNORD113-8&recr=Open">Click here</a>	
SNRNP200	Silent	p.F1451F	G	G		11	Filtered Calls	2	96950135	96950135	73	0.232876712328767	NA	NA	NA			90	Helicase ATP-binding 2. {ECO:0000255|PROSITE-ProRule:PRU00541}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRNP200&recr=Open">Click here</a>	
SNRPN	Silent	p.G214G	G	G		11	Filtered Calls	15	25223410	25223410	62	0.161290322580645	NA	NA	NA			24	Repeat-rich region.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SNRPN&recr=Open">Click here</a>	
SORCS2	Silent	p.S967S	C	C		11	Filtered Calls	4	7730108	7730108	24	0.416666666666667	NA	NA	NA			42			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS2&recr=Open">Click here</a>	
SORCS3	Silent	p.R718R	G	G	rs267602359	11	Filtered Calls	10	106960904	106960904	65	0.2	NA	NA	NA			131			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORCS3&recr=Open">Click here</a>	
SORL1	Intron		C	C		11	Filtered Calls	11	121391356	121391356	52	0.653846153846154	NA	NA	NA			91			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SORL1&recr=Open">Click here</a>	
SPAG9	Intron		G	G		11	Filtered Calls	17	49084697	49084697	139	0.611510791366906	NA	NA	NA			37			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPAG9&recr=Open">Click here</a>	
SPARC	Intron		G	G		11	Filtered Calls	5	151054248	151054248	105	0.228571428571429	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SPARC&recr=Open">Click here</a>	
SSH3	5'Flank		C	C		11	Filtered Calls	11	67068820	67068820	26	0.538461538461538	NA	NA	NA			19			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SSH3&recr=Open">Click here</a>	
STARD13	Silent	p.K247K	C	C		11	Filtered Calls	13	33704073	33704073	91	0.373626373626374	NA	NA	NA			40			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STARD13&recr=Open">Click here</a>	
STC1	Silent	p.R158R	C	C		11	Filtered Calls	8	23702346	23702346	50	0.12	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STC1&recr=Open">Click here</a>	
STON2	Intron		G	G		11	Filtered Calls	14	81745091	81745091	59	0.406779661016949	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+STON2&recr=Open">Click here</a>	
SYBU	Silent	p.S527S	C	C		11	Filtered Calls	8	110587543	110587543	75	0.333333333333333	NA	NA	NA			30			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYBU&recr=Open">Click here</a>	
SYT16	Silent	p.F579F	C	C		11	Filtered Calls	14	62567224	62567224	41	0.536585365853659	NA	NA	NA			35	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+SYT16&recr=Open">Click here</a>	
TACC2	Silent	p.P515P	C	C		11	Filtered Calls	10	123843560	123843560	53	0.471698113207547	NA	NA	NA			83	Pro-rich.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TACC2&recr=Open">Click here</a>	
TAS2R1	Silent	p.L118L	A	A		11	Filtered Calls	5	9629793	9629793	35	0.285714285714286	NA	NA	NA			39			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TAS2R1&recr=Open">Click here</a>	
TENC1	Intron		C	C		11	Filtered Calls	12	53447186	53447186	40	0.45	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENC1&recr=Open">Click here</a>	
TENC1	Intron		C	C		11	Filtered Calls	12	53447187	53447187	40	0.45	NA	NA	NA			34			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENC1&recr=Open">Click here</a>	
TENM1	Silent	p.G2569G	C	C		11	Filtered Calls	X	123514857	123514857	45	0.644444444444444	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM1&recr=Open">Click here</a>	
TENM3	Silent	p.F445F	C	C		11	Filtered Calls	4	183600827	183600827	60	0.316666666666667	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TENM3&recr=Open">Click here</a>	
TEX26	Silent	p.L139L	A	A		11	Filtered Calls	13	31531114	31531114	156	0.391025641025641	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TEX26&recr=Open">Click here</a>	
TF	Silent	p.T269T	C	C		11	Filtered Calls	3	133475790	133475790	46	0.456521739130435	NA	NA	NA			49	Transferrin-like 1. {ECO:0000255|PROSITE- ProRule:PRU00741}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TF&recr=Open">Click here</a>	
TGM6	Silent	p.I582I	C	C		11	Filtered Calls	20	2411159	2411159	82	0.25609756097561	NA	NA	NA			52			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TGM6&recr=Open">Click here</a>	
THBS2	Silent	p.S138S	G	G		11	Filtered Calls	6	169648707	169648707	60	0.35	NA	NA	NA		p.S138S(1)	111	Heparin-binding. {ECO:0000255}.|Laminin G-like.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+THBS2&recr=Open">Click here</a>	
TMC7	Silent	p.S48S	C	C		11	Filtered Calls	16	19020570	19020570	87	0.505747126436782	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMC7&recr=Open">Click here</a>	
TMCO5A	Intron		G	G		11	Filtered Calls	15	38233417	38233417	46	0.304347826086957	NA	NA	NA			15			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMCO5A&recr=Open">Click here</a>	
TMX4	Intron		G	G		11	Filtered Calls	20	7964512	7964512	86	0.313953488372093	NA	NA	NA			17			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TMX4&recr=Open">Click here</a>	
TNFAIP2	Intron		C	C		11	Filtered Calls	14	103599694	103599694	30	0.233333333333333	NA	NA	NA			11			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNFAIP2&recr=Open">Click here</a>	
TNP1	Silent	p.G44G	G	G	rs549619953	11	Filtered Calls	2	217724626	217724626	128	0.03125	NA	NA	NA			3			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNP1&recr=Open">Click here</a>	
TNR	Silent	p.S766S	G	G		11	Filtered Calls	1	175335030	175335030	62	0.629032258064516	NA	NA	NA			177	Fibronectin type-III 5. {ECO:0000255|PROSITE-ProRule:PRU00316}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TNR&recr=Open">Click here</a>	
TPO	Silent	p.G860G	A	A		11	Filtered Calls	2	1520716	1520716	40	0.2	NA	NA	NA			95			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPO&recr=Open">Click here</a>	
TPTE	Silent	p.L408L	G	G		11	Filtered Calls	21	10916422	10916422	151	0.105960264900662	NA	NA	NA			130			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE&recr=Open">Click here</a>	
TPTE2	Silent	p.R314R	C	C		11	Filtered Calls	13	20010420	20010420	75	0.16	NA	NA	NA			65	Phosphatase tensin-type. {ECO:0000255|PROSITE-ProRule:PRU00590}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TPTE2&recr=Open">Click here</a>	
TRAV8-6	RNA		G	G		11	Filtered Calls	14	22447134	22447134	104	0.201923076923077	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRAV8-6&recr=Open">Click here</a>	
TRBV25-1	RNA		G	G		11	Filtered Calls	7	142378960	142378960	94	0.382978723404255	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV25-1&recr=Open">Click here</a>	
TRBV6-9	RNA		C	C		11	Filtered Calls	7	142104332	142104332	96	0.291666666666667	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRBV6-9&recr=Open">Click here</a>	
TRMT61A	Silent	p.L250L	G	G		11	Filtered Calls	14	104001038	104001038	12	0.583333333333333	NA	NA	NA			1			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TRMT61A&recr=Open">Click here</a>	
TTN	Silent	p.F5732F	G	G		11	Filtered Calls	2	179596297	179596297	22	0.136363636363636	NA	NA	NA			1448	Ig-like 38.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTN&recr=Open">Click here</a>	
TTYH2	Silent	p.T92T	G	G	rs137871085	11	Filtered Calls	17	72218770	72218770	59	0.525423728813559	NA	NA	NA			36			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+TTYH2&recr=Open">Click here</a>	
UAP1	Silent	p.F264F	C	C		11	Filtered Calls	1	162551207	162551207	143	0.734265734265734	NA	NA	NA			22			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UAP1&recr=Open">Click here</a>	
UGT1A6	Intron		G	G		11	Filtered Calls	2	234652139	234652139	30	0.2	NA	NA	NA			22			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT1A6&recr=Open">Click here</a>	
UGT2B4	Intron		G	G		11	Filtered Calls	4	70351154	70351154	81	0.259259259259259	NA	NA	NA			47			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+UGT2B4&recr=Open">Click here</a>	
USH1C	Intron		G	G		11	Filtered Calls	11	17552851	17552851	22	0.545454545454545	NA	NA	NA			48			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+USH1C&recr=Open">Click here</a>	
VCPIP1	Silent	p.A251A	G	G		11	Filtered Calls	8	67578441	67578441	106	0.292452830188679	NA	NA	NA			45	OTU. {ECO:0000255|PROSITE- ProRule:PRU00139}.		MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+VCPIP1&recr=Open">Click here</a>	
XDH	Silent	p.T1004T	G	G		11	Filtered Calls	2	31571804	31571804	49	0.36734693877551	NA	NA	NA			74			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+XDH&recr=Open">Click here</a>	
ZC3H13	Silent	p.S1138S	G	G		11	Filtered Calls	13	46543265	46543265	59	0.389830508474576	NA	NA	NA			79			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZC3H13&recr=Open">Click here</a>	
ZDHHC2	Silent	p.L280L	T	T		11	Filtered Calls	8	17067548	17067548	27	0.62962962962963	NA	NA	NA			8			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZDHHC2&recr=Open">Click here</a>	
ZIM3	Silent	p.L238L	G	G		11	Filtered Calls	19	57646991	57646991	95	0.326315789473684	NA	NA	NA			52			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZIM3&recr=Open">Click here</a>	
ZNF287	5'Flank		G	G		11	Filtered Calls	17	16470835	16470835	128	0.3203125	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF287&recr=Open">Click here</a>	
ZNF311	Intron		G	G		11	Filtered Calls	6	28964373	28964373	106	0.283018867924528	NA	NA	NA			28			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF311&recr=Open">Click here</a>	
ZNF564	Silent	p.R382R	T	T		11	Filtered Calls	19	12637776	12637776	91	0.153846153846154	NA	NA	NA			18			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF564&recr=Open">Click here</a>	
ZNF823	Silent	p.F569F	G	G		11	Filtered Calls	19	11832642	11832642	106	0.462264150943396	NA	NA	NA			26			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZNF823&recr=Open">Click here</a>	
ZSCAN25	Silent	p.V502V	C	C		11	Filtered Calls	7	99227514	99227514	49	0.408163265306122	NA	NA	NA			NA			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZSCAN25&recr=Open">Click here</a>	
ZWINT	Intron		G	G	rs191476918	11	Filtered Calls	10	58119229	58119229	55	0.454545454545455	NA	NA	NA			20			MEL-IPI_Pat109-Tumor-SM-4CU6W	<a href="http://clinicaltrials.gov/ct2/results?term=Melanoma+AND+cancer+AND+ZWINT&recr=Open">Click here</a>	
